{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T21:03:00Z","timestamp":1778360580545,"version":"3.51.4"},"reference-count":258,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2021,11,8]]},"abstract":"<jats:sec><jats:title\/><jats:p>Aging is an important stage of the human life cycle and the primary risk factor for Neurodegenerative Diseases (ND). The aging process contributes to modifications in cells, which may lead to a lack of nutrient signaling, disrupted cellular activity, increased oxidative pressure, cell homeostasis depletion, genomic instability, misfolded protein aggregation, impaired cellular protection, and telomere reduction. The neuropathologies found in Alzheimer&amp;#039;s Disease (AD) and Parkinson&amp;#039;s Disease (PD) are internally and extrinsically compound environmental stressors which may be partially alleviated by using different phytochemicals. The new therapies for ND are restricted as they are primarily targeted at final disease progression, including behavioral shifts, neurological disorders, proteinopathies and neuronal failure. This review presents the role of phytochemicals-related polyphenolic compounds as an accompanying therapy model to avoid neuropathologies linked to AD, PD and to simultaneously enhance two stochastic stressors, namely inflammation and oxidative stress, promoting their disease pathologies. Therefore, this approach represents a prophylactic way to target risk factors that rely on their action against ND that does not occur through current pharmacological agents over the life of a person.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871527320666210218084444","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T15:56:46Z","timestamp":1613750206000},"page":"430-450","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases"],"prefix":"10.2174","volume":"20","author":[{"given":"Rokeya","family":"Akter","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Jagannath University, Sadarghat, Dhaka-1100, Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Southeast University, Banani 42130, Dhaka-1213, Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Arifur Rahman","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Bioactive Materials Science, Jeonbuk National University, Jeonju-si, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Manirujjaman","sequence":"additional","affiliation":[{"name":"Institute of Health and Biomedical Innovation (IHBI), School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Kelvin Grove, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israt Jahan","family":"Bulbul","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Southeast University, Banani 42130, Dhaka-1213, Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimaa E.","family":"Elshenaw","sequence":"additional","affiliation":[{"name":"Center of Stem Cell and Regenerative Medicine, Zewail City for Science, Giza, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia Mirela","family":"Tit","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 101 Decembrie Sq., 410073 Oradea, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bungau","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 101 Decembrie Sq., 410073 Oradea, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nbd.2015.04.008","volume":"84","author":"Verdile G.","year":"2015","unstructured":"Verdile G.; Fuller S.J.; Martins R.N.; The role of type 2 diabetes in neurodegeneration. Neurobiol Dis 2015,84,22-38","journal-title":"Neurobiol Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrn3887","volume":"16","author":"Brettschneider J.","year":"2015","unstructured":"Brettschneider J.; Del Tredici K.; Lee V.M.; Trojanowski J.Q.; Spreading of pathology in neurodegenerative diseases: A focus on human studies. Nat Rev Neurosci 2015,16(2),109-120","journal-title":"Nat Rev Neurosci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"Soto C.","year":"2003","unstructured":"Soto C.; Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 2003,4(1),49-60","journal-title":"Nat Rev Neurosci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","volume":"13","author":"Al-Chalabi A.","year":"2017","unstructured":"Al-Chalabi A.; van den Berg L.H.; Veldink J.; Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nat Rev Neurol 2017,13(2),96-104","journal-title":"Nat Rev Neurol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/JCI200317522","volume":"111","author":"Przedborski S.","year":"2003","unstructured":"Przedborski S.; Vila M.; Jackson-Lewis V.; Neurodegeneration: What is it and where are we? J Clin Invest 2003,111(1),3-10","journal-title":"J Clin Invest"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/10715762.2017.1315114","volume":"51","author":"Umeno A.","year":"2017","unstructured":"Umeno A.; Biju V.; Yoshida Y.; In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer\u2019s disease, Parkinson\u2019s disease, and diabetes. Free Radic Res 2017,51(4),413-427","journal-title":"Free Radic Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"Kowal S.L.","year":"2013","unstructured":"Kowal S.L.; Dall T.M.; Chakrabarti R.; Storm M.V.; Jain A.; The current and projected economic burden of Parkinson\u2019s disease in the United States. Mov Disord 2013,28(3),311-318","journal-title":"Mov Disord"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"Kalia L.V.","year":"2015","unstructured":"Kalia L.V.; Lang A.E.; Parkinson\u2019s disease. Lancet 2015,386(9996),896-912","journal-title":"Lancet"},{"key":"ref=9","author":"Giudicessi J.R.","year":"2020","unstructured":"Giudicessi J.R.; Noseworthy P.A.; Friedman P.A.; Ackerman M.J.; Mayo Foundation for Medical Education and Research https:\/\/www.mayo.edu\/2020","journal-title":"Mayo Foundation for Medical Education and Research"},{"key":"ref=10","first-page":"9832839","volume":"2016","author":"Magrinelli F.","year":"2016","unstructured":"Magrinelli F.; Picelli A.; Tocco P.; Federico A.; Roncari L.; Smania N.; Pathophysiology of motor dysfunction in parkinson\u2019s disease as the rationale for drug treatment and rehabilitation. Parkinson\u2019s Dis 2016,2016,9832839","journal-title":"Parkinson\u2019s Dis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"Dauer W.","year":"2003","unstructured":"Dauer W.; Przedborski S.; Parkinson\u2019s disease: Mechanisms and models. Neuron 2003,39(6),889-909","journal-title":"Neuron"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"120080","DOI":"10.1098\/rsob.120080","volume":"2","author":"Kondapalli C.","year":"2012","unstructured":"Kondapalli C.; Kazlauskaite A.; Zhang N.; Woodroof H.I.; Campbell D.G.; Gourlay R.; Burchell L.; Walden H.; Macartney T.J.; Deak M.; Knebel A.; Alessi D.R.; Muqit M.M.; PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol 2012,2(5),120080","journal-title":"Open Biol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e34693","DOI":"10.1371\/journal.pone.0034693","volume":"7","author":"Kim B.","year":"2012","unstructured":"Kim B.; Yang M.S.; Choi D.; Kim J.H.; Kim H.S.; Seol W.; Choi S.; Jou I.; Kim E.Y.; Joe E.H.; Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia. PLoS One 2012,7(4),e34693","journal-title":"PLoS One"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","volume":"28","author":"Appel-Cresswell S.","year":"2013","unstructured":"Appel-Cresswell S.; Vilarino-Guell C.; Encarnacion M.; Sherman H.; Yu I.; Shah B.; Weir D.; Thompson C.; Szu-Tu C.; Trinh J.; Aasly J.O.; Rajput A.; Rajput A.H.; Jon Stoessl A.; Farrer M.J.; Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov Disord 2013,28(6),811-813","journal-title":"Mov Disord"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"Kitada T.","year":"1998","unstructured":"Kitada T.; Asakawa S.; Hattori N.; Matsumine H.; Yamamura Y.; Minoshima S.; Yokochi M.; Mizuno Y.; Shimizu N.; Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998,392(6676),605-608","journal-title":"Nature"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10072-003-0108-0","volume":"24","author":"Bonifati V.","year":"2003","unstructured":"Bonifati V.; Rizzu P.; Squitieri F.; Krieger E.; Vanacore N.; van Swieten J.C.; Brice A.; van Duijn C.M.; Oostra B.; Meco G.; Heutink P.; DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 2003,24(3),159-160","journal-title":"Neurol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.parkreldis.2013.01.020","volume":"19","author":"Puschmann A.","year":"2013","unstructured":"Puschmann A.; Monogenic Parkinson\u2019s disease and parkinsonism: Clinical phenotypes and frequencies of known mutations. Parkinsonism Relat Disord 2013,19(4),407-415","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"Zimprich A.","year":"2004","unstructured":"Zimprich A.; Biskup S.; Leitner P.; Lichtner P.; Farrer M.; Lincoln S.; Kachergus J.; Hulihan M.; Uitti R.J.; Calne D.B.; Stoessl A.J.; Pfeiffer R.F.; Patenge N.; Carbajal I.C.; Vieregge P.; Asmus F.; M\u00fcller-Myhsok B.; Dickson D.W.; Meitinger T.; Strom T.M.; Wszolek Z.K.; Gasser T.; Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004,44(4),601-607","journal-title":"Neuron"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"Pais\u00e1n-Ru\u00edz C.","year":"2004","unstructured":"Pais\u00e1n-Ru\u00edz C.; Jain S.; Evans E.W.; Gilks W.P.; Sim\u00f3n J.; van der Brug M.; L\u00f3pez de Munain A.; Aparicio S.; Gil A.M.; Khan N.; Johnson J.; Martinez J.R.; Nicholl D.; Mart\u00ed Carrera I.; Pena A.S.; de Silva R.; Lees A.; Mart\u00ed-Mass\u00f3 J.F.; P\u00e9rez-Tur J.; Wood N.W.; Singleton A.B.; Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 2004,44(4),595-600","journal-title":"Neuron"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","volume":"10","author":"McCormack A.L.","year":"2002","unstructured":"McCormack A.L.; Thiruchelvam M.; Manning-Bog A.B.; Thiffault C.; Langston J.W.; Cory-Slechta D.A.; Di Monte D.A.; Environmental risk factors and Parkinson\u2019s disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 2002,10(2),119-127","journal-title":"Neurobiol Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","volume":"302","author":"Dzamko N.","year":"2015","unstructured":"Dzamko N.; Geczy C.L.; Halliday G.M.; Inflammation is genetically implicated in Parkinson\u2019s disease. Neuroscience 2015,302,89-102","journal-title":"Neuroscience"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"Wu D.C.","year":"2002","unstructured":"Wu D.C.; Jackson-Lewis V.; Vila M.; Tieu K.; Teismann P.; Vadseth C.; Choi D.K.; Ischiropoulos H.; Przedborski S.; Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 2002,22(5),1763-1771","journal-title":"J Neurosci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnagi.2018.00012","volume":"10","author":"L\u2019Episcopo F.","year":"2018","unstructured":"L\u2019Episcopo F.; Tirolo C.; Serapide M.F.; Caniglia S.; Testa N.; Leggio L.; Vivarelli S.; Iraci N.; Pluchino S.; Marchetti B.; Microglia polarization, gene-environment interactions and WNT\/\u03b2-catenin signaling: Emerging roles of glia-neuron and glia-stem\/neuroprogenitor crosstalk for dopaminergic neurorestoration in aged parkinsonian Brain. Front Aging Neurosci 2018,10,12","journal-title":"Front Aging Neurosci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.31925\/farmacia.2019.3.15","volume":"67","author":"Purza L.","year":"2019","unstructured":"Purza L.; Abdel-Daim M.; Belba A.; Monitoring the effects of various combination of specific drug therapies at different stages of Alzheimer\u2032s dementia. Farmacia 2019,67(3),477-481","journal-title":"Farmacia"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1749-6632.1999.tb07845.x","volume":"893","author":"Klein A.M.","year":"1999","unstructured":"Klein A.M.; Kowall N.W.; Ferrante R.J.; Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex. Ann N Y Acad Sci 1999,893,314-320","journal-title":"Ann N Y Acad Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.arr.2010.04.007","volume":"9","author":"Frisardi V.","year":"2010","unstructured":"Frisardi V.; Solfrizzi V.; Seripa D.; Capurso C.; Santamato A.; Sancarlo D.; Vendemiale G.; Pilotto A.; Panza F.; Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer\u2019s disease. Ageing Res Rev 2010,9(4),399-417","journal-title":"Ageing Res Rev"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"Van Cauwenberghe C.","year":"2016","unstructured":"Van Cauwenberghe C.; Van Broeckhoven C.; Sleegers K.; The genetic landscape of Alzheimer disease: Clinical implications and perspectives. Genet Med 2016,18(5),421-430","journal-title":"Genet Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0065-2776(10)06002-5","volume":"106","author":"Saijo K.","year":"2010","unstructured":"Saijo K.; Crotti A.; Glass C.K.; Nuclear receptors, inflammation, and neurodegenerative diseases. Adv Immunol 2010,106,21-59","journal-title":"Adv Immunol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0197-4580(99)00110-4","volume":"21","author":"Breteler M.M.","year":"2000","unstructured":"Breteler M.M.; Vascular risk factors for Alzheimer\u2019s disease: An epidemiologic perspective. Neurobiol Aging 2000,21(2),153-160","journal-title":"Neurobiol Aging"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1212\/01.WNL.0000144281.38555.E3","volume":"63","author":"Solfrizzi V.","year":"2004","unstructured":"Solfrizzi V.; Panza F.; Colacicco A.M.; D\u2019Introno A.; Capurso C.; Torres F.; Grigoletto F.; Maggi S.; Del Parigi A.; Reiman E.M.; Caselli R.J.; Scafato E.; Farchi G.; Capurso A.; Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology Italian longitudinal study on aging working group2004,63(10),1882-1891","journal-title":"Neurology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"Gatz M.","year":"2006","unstructured":"Gatz M.; Reynolds C.A.; Fratiglioni L.; Johansson B.; Mortimer J.A.; Berg S.; Fiske A.; Pedersen N.L.; Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 2006,63(2),168-174","journal-title":"Arch Gen Psychiatry"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","volume":"10","author":"Michaelson D.M.","year":"2014","unstructured":"Michaelson D.M.; APOE \u03b54: The most prevalent yet understudied risk factor for Alzheimer\u2019s disease. Alzheimers Dement 2014,10(6),861-868","journal-title":"Alzheimers Dement"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"Kim J.","year":"2009","unstructured":"Kim J.; Basak J.M.; Holtzman D.M.; The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron 2009,63(3),287-303","journal-title":"Neuron"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2014.05.041","volume":"83","author":"Karch C.M.","year":"2014","unstructured":"Karch C.M.; Cruchaga C.; Goate A.M.; Alzheimer\u2019s disease genetics: From the bench to the clinic. Neuron 2014,83(1),11-26","journal-title":"Neuron"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"Sims R.","year":"2017","unstructured":"Sims R.; van der Lee S.J.; Naj A.C.; Bellenguez C.; Badarinarayan N.; Jakobsdottir J.; Kunkle B.W.; Boland A.; Raybould R.; Bis J.C.; Martin E.R.; Grenier-Boley B.; Heilmann-Heimbach S.; Chouraki V.; Kuzma A.B.; Sleegers K.; Vronskaya M.; Ruiz A.; Graham R.R.; Olaso R.; Hoffmann P.; Grove M.L.; Vardarajan B.N.; Hiltunen M.; N\u00f6then M.M.; White C.C.; Hamilton-Nelson K.L.; Epelbaum J.; Maier W.; Choi S.H.; Beecham G.W.; Dulary C.; Herms S.; Smith A.V.; Funk C.C.; Derbois C.; Forstner A.J.; Ahmad S.; Li H.; Bacq D.; Harold D.; Satizabal C.L.; Valladares O.; Squassina A.; Thomas R.; Brody J.A.; Qu L.; S\u00e1nchez-Juan P.; Morgan T.; Wolters F.J.; Zhao Y.; Garcia F.S.; Denning N.; Fornage M.; Malamon J.; Naranjo M.C.D.; Majounie E.; Mosley T.H.; Dombroski B.; Wallon D.; Lupton M.K.; Dupuis J.; Whitehead P.; Fratiglioni L.; Medway C.; Jian X.; Mukherjee S.; Keller L.; Brown K.; Lin H.; Cantwell L.B.; Panza F.; McGuinness B.; Moreno-Grau S.; Burgess J.D.; Solfrizzi V.; Proitsi P.; Adams H.H.; Allen M.; Seripa D.; Pastor P.; Cupples L.A.; Price N.D.; Hannequin D.; Frank-Garc\u00eda A.; Levy D.; Chakrabarty P.; Caffarra P.; Giegling I.; Beiser A.S.; Giedraitis V.; Hampel H.; Garcia M.E.; Wang X.; Lannfelt L.; Mecocci P.; Eiriksdottir G.; Crane P.K.; Pasquier F.; Boccardi V.; Hen\u00e1ndez I.; Barber R.C.; Scherer M.; Tarraga L.; Adams P.M.; Leber M.; Chen Y.; Albert M.S.; Riedel-Heller S.; Emilsson V.; Beekly D.; Braae A.; Schmidt R.; Blacker D.; Masullo C.; Schmidt H.; Doody R.S.; Spalletta G.; Longstreth W.T.; Fairchild T.J.; Boss\u00f9 P.; Lopez O.L.; Frosch M.P.; Sacchinelli E.; Ghetti B.; Yang Q.; Huebinger R.M.; Jessen F.; Li S.; Kamboh M.I.; Morris J.; Sotolongo-Grau O.; Katz M.J.; Corcoran C.; Dunstan M.; Braddel A.; Thomas C.; Meggy A.; Marshall R.; Gerrish A.; Chapman J.; Aguilar M.; Taylor S.; Hill M.; Fair\u00e9n M.D.; Hodges A.; Vellas B.; Soininen H.; Kloszewska I.; Daniilidou M.; Uphill J.; Patel Y.; Hughes J.T.; Lord J.; Turton J.; Hartmann A.M.; Cecchetti R.; Fenoglio C.; Serpente M.; Arcaro M.; Caltagirone C.; Orfei M.D.; Ciaramella A.; Pichler S.; Mayhaus M.; Gu W.; Lle\u00f3 A.; Fortea J.; Blesa R.; Barber I.S.; Brookes K.; Cupidi C.; Maletta R.G.; Carrell D.; Sorbi S.; Moebus S.; Urbano M.; Pilotto A.; Kornhuber J.; Bosco P.; Todd S.; Craig D.; Johnston J.; Gill M.; Lawlor B.; Lynch A.; Fox N.C.; Hardy J.; Albin R.L.; Apostolova L.G.; Arnold S.E.; Asthana S.; Atwood C.S.; Baldwin C.T.; Barnes L.L.; Barral S.; Beach T.G.; Becker J.T.; Bigio E.H.; Bird T.D.; Boeve B.F.; Bowen J.D.; Boxer A.; Burke J.R.; Burns J.M.; Buxbaum J.D.; Cairns N.J.; Cao C.; Carlson C.S.; Carlsson C.M.; Carney R.M.; Carrasquillo M.M.; Carroll S.L.; Diaz C.C.; Chui H.C.; Clark D.G.; Cribbs D.H.; Crocco E.A.; DeCarli C.; Dick M.; Duara R.; Evans D.A.; Faber K.M.; Fallon K.B.; Fardo D.W.; Farlow M.R.; Ferris S.; Foroud T.M.; Galasko D.R.; Gearing M.; Geschwind D.H.; Gilbert J.R.; Graff-Radford N.R.; Green R.C.; Growdon J.H.; Hamilton R.L.; Harrell L.E.; Honig L.S.; Huentelman M.J.; Hulette C.M.; Hyman B.T.; Jarvik G.P.; Abner E.; Jin L.W.; Jun G.; Karydas A.; Kaye J.A.; Kim R.; Kowall N.W.; Kramer J.H.; LaFerla F.M.; Lah J.J.; Leverenz J.B.; Levey A.I.; Li G.; Lieberman A.P.; Lunetta K.L.; Lyketsos C.G.; Marson D.C.; Martiniuk F.; Mash D.C.; Masliah E.; McCormick W.C.; McCurry S.M.; McDavid A.N.; McKee A.C.; Mesulam M.; Miller B.L.; Miller C.A.; Miller J.W.; Morris J.C.; Murrell J.R.; Myers A.J.; O\u2019Bryant S.; Olichney J.M.; Pankratz V.S.; Parisi J.E.; Paulson H.L.; Perry W.; Peskind E.; Pierce A.; Poon W.W.; Potter H.; Quinn J.F.; Raj A.; Raskind M.; Reisberg B.; Reitz C.; Ringman J.M.; Roberson E.D.; Rogaeva E.; Rosen H.J.; Rosenberg R.N.; Sager M.A.; Saykin A.J.; Schneider J.A.; Schneider L.S.; Seeley W.W.; Smith A.G.; Sonnen J.A.; Spina S.; Stern R.A.; Swerdlow R.H.; Tanzi R.E.; Thornton-Wells T.A.; Trojanowski J.Q.; Troncoso J.C.; Van Deerlin V.M.; Van Eldik L.J.; Vinters H.V.; Vonsattel J.P.; Weintraub S.; Welsh-Bohmer K.A.; Wilhelmsen K.C.; Williamson J.; Wingo T.S.; Woltjer R.L.; Wright C.B.; Yu C.E.; Yu L.; Garzia F.; Golamaully F.; Septier G.; Engelborghs S.; Vandenberghe R.; De Deyn P.P.; Fernadez C.M.; Benito Y.A.; Thonberg H.; Forsell C.; Lilius L.; Kinhult-St\u00e4hlbom A.; Kilander L.; Brundin R.; Concari L.; Helisalmi S.; Koivisto A.M.; Haapasalo A.; Dermecourt V.; Fievet N.; Hanon O.; Dufouil C.; Brice A.; Ritchie K.; Dubois B.; Himali J.J.; Keene C.D.; Tschanz J.; Fitzpatrick A.L.; Kukull W.A.; Norton M.; Aspelund T.; Larson E.B.; Munger R.; Rotter J.I.; Lipton R.B.; Bullido M.J.; Hofman A.; Montine T.J.; Coto E.; Boerwinkle E.; Petersen R.C.; Alvarez V.; Rivadeneira F.; Reiman E.M.; Gallo M.; O\u2019Donnell C.J.; Reisch J.S.; Bruni A.C.; Royall D.R.; Dichgans M.; Sano M.; Galimberti D.; St George-Hyslop P.; Scarpini E.; Tsuang D.W.; Mancuso M.; Bonuccelli U.; Winslow A.R.; Daniele A.; Wu C.K.; Peters O.; Nacmias B.; Riemenschneider M.; Heun R.; Brayne C.; Rubinsztein D.C.; Bras J.; Guerreiro R.; Al-Chalabi A.; Shaw C.E.; Collinge J.; Mann D.; Tsolaki M.; Clarim\u00f3n J.; Sussams R.; Lovestone S.; O\u2019Donovan M.C.; Owen M.J.; Behrens T.W.; Mead S.; Goate A.M.; Uitterlinden A.G.; Holmes C.; Cruchaga C.; Ingelsson M.; Bennett D.A.; Powell J.; Golde T.E.; Graff C.; De Jager P.L.; Morgan K.; Ertekin-Taner N.; Combarros O.; Psaty B.M.; Passmore P.; Younkin S.G.; Berr C.; Gudnason V.; Rujescu D.; Dickson D.W.; Dartigues J.F.; DeStefano A.L.; Ortega-Cubero S.; Hakonarson H.; Campion D.; Boada M.; Kauwe J.K.; Farrer L.A.; Van Broeckhoven C.; Ikram M.A.; Jones L.; Haines J.L.; Tzourio C.; Launer L.J.; Escott-Price V.; Mayeux R.; Deleuze J.F.; Amin N.; Holmans P.A.; Pericak-Vance M.A.; Amouyel P.; van Duijn C.M.; Ramirez A.; Wang L.S.; Lambert J.C.; Seshadri S.; Williams J.; Schellenberg G.D.; Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet ARUK Consortium2017,49(9),1373-1384","journal-title":"Nat Genet"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng.3246","volume":"47","author":"Steinberg S.","year":"2015","unstructured":"Steinberg S.; Stefansson H.; Jonsson T.; Johannsdottir H.; Ingason A.; Helgason H.; Sulem P.; Magnusson O.T.; Gudjonsson S.A.; Unnsteinsdottir U.; Kong A.; Helisalmi S.; Soininen H.; Lah J.J.; Aarsland D.; Fladby T.; Ulstein I.D.; Djurovic S.; Sando S.B.; White L.R.; Knudsen G.P.; Westlye L.T.; Selb\u00e6k G.; Giegling I.; Hampel H.; Hiltunen M.; Levey A.I.; Andreassen O.A.; Rujescu D.; Jonsson P.V.; Bjornsson S.; Snaedal J.; Stefansson K.; Loss-of- function variants in ABCA7 confer risk of Alzheimer\u2019s disease. Nat Genet DemGene2015,47(5),445-447","journal-title":"Nat Genet"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"Farrer L.A.","year":"1997","unstructured":"Farrer L.A.; Cupples L.A.; Haines J.L.; Hyman B.; Kukull W.A.; Mayeux R.; Myers R.H.; Pericak-Vance M.A.; Risch N.; van Duijn C.M.; Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA APOE and alzheimer disease meta analysis consortium1997,278(16),1349-1356","journal-title":"JAMA"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"Jankovic J.","year":"2008","unstructured":"Jankovic J.; Parkinson\u2019s disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008,79(4),368-376","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/mds.21813","volume":"23","author":"O\u2019Sullivan S.S.","year":"2008","unstructured":"O\u2019Sullivan S.S.; Williams D.R.; Gallagher D.A.; Massey L.A.; Silveira-Moriyama L.; Lees A.J.; Nonmotor symptoms as presenting complaints in Parkinson\u2019s disease: A clinicopathological study. Mov Disord 2008,23(1),101-106","journal-title":"Mov Disord"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.20791","volume":"59","author":"Giasson B.I.","year":"2006","unstructured":"Giasson B.I.; Covy J.P.; Bonini N.M.; Hurtig H.I.; Farrer M.J.; Trojanowski J.Q.; Van Deerlin V.M.; Biochemical and pathological characterization of Lrrk2. Ann Neurol 2006,59(2),315-322","journal-title":"Ann Neurol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ana.24011","volume":"74","author":"Olanow C.W.","year":"2013","unstructured":"Olanow C.W.; Schapira A.H.; Therapeutic prospects for Parkinson disease. Ann Neurol 2013,74(3),337-347","journal-title":"Ann Neurol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/S1353-8020(13)70017-8","volume":"20","author":"McCann H.","year":"2014","unstructured":"McCann H.; Stevens C.H.; Cartwright H.; Halliday G.M.; \u03b1-Synucleinopathy phenotypes. Parkinsonism Relat Disord 2014,20(Suppl. 1),S62-S67","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"Cox D.B.","year":"2015","unstructured":"Cox D.B.; Platt R.J.; Zhang F.; Therapeutic genome editing: Prospects and challenges. Nat Med 2015,21(2),121-131","journal-title":"Nat Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.bbadis.2013.09.007","volume":"1842","author":"Jin H.","year":"2014","unstructured":"Jin H.; Kanthasamy A.; Ghosh A.; Anantharam V.; Kalyanaraman B.; Kanthasamy A.G.; Mitochondria-targeted antioxidants for treatment of Parkinson\u2019s disease: Preclinical and clinical outcomes. Biochim Biophys Acta 2014,1842(8),1282-1294","journal-title":"Biochim Biophys Acta"},{"key":"ref=45","first-page":"90","volume":"2","author":"Doorn K.J.","year":"2014","unstructured":"Doorn K.J.; Moors T.; Drukarch B.; van de Berg W.Dj.; Lucassen P.J.; van Dam A.M.; Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson\u2019s disease patients. Acta Neuropathol Commun 2014,2(1),90","journal-title":"Acta Neuropathol Commun"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"McGeer P.L.","year":"1988","unstructured":"McGeer P.L.; Itagaki S.; Boyes B.E.; McGeer E.G.; Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 1988,38(8),1285-1291","journal-title":"Neurology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"Imamura K.","year":"2003","unstructured":"Imamura K.; Hishikawa N.; Sawada M.; Nagatsu T.; Yoshida M.; Hashizume Y.; Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol 2003,106(6),518-526","journal-title":"Acta Neuropathol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Yan Y.","year":"2015","unstructured":"Yan Y.; Jiang W.; Liu L.; Wang X.; Ding C.; Tian Z.; Zhou R.; Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 2015,160(1-2),62-73","journal-title":"Cell"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e0162717","DOI":"10.1371\/journal.pone.0162717","volume":"11","author":"Hoenen C.","year":"2016","unstructured":"Hoenen C.; Gustin A.; Birck C.; Kirchmeyer M.; Beaume N.; Felten P.; Grandbarbe L.; Heuschling P.; Heurtaux T.; Alpha-synuclein proteins promote pro-inflammatory cascades in microglia: Stronger effects of the A53T mutant. PLoS One 2016,11(9),e0162717","journal-title":"PLoS One"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20150617","volume":"471","author":"Gustot A.","year":"2015","unstructured":"Gustot A.; Gallea J.I.; Sarroukh R.; Celej M.S.; Ruysschaert J.M.; Raussens V.; Amyloid fibrils are the molecular trigger of inflammation in Parkinson\u2019s disease. Biochem J 2015,471(3),323-333","journal-title":"Biochem J"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"Codolo G.","year":"2013","unstructured":"Codolo G.; Plotegher N.; Pozzobon T.; Brucale M.; Tessari I.; Bubacco L.; de Bernard M.; Triggering of inflammasome by aggregated \u03b1-synuclein, an inflammatory response in synucleinopathies. PLoS One 2013,8(1)","journal-title":"PLoS One"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/mds.26488","volume":"31","author":"Zhang P.","year":"2016","unstructured":"Zhang P.; Shao X.Y.; Qi G.J.; Chen Q.; Bu L.L.; Chen L.J.; Shi J.; Ming J.; Tian B.; Cdk5-dependent activation of neuronal inflammasomes in parkinson\u2019s disease. Mov Disord 2016,31(3),366-376","journal-title":"Mov Disord"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.neurobiolaging.2013.08.015","volume":"35","author":"Lu M.","year":"2014","unstructured":"Lu M.; Sun X.L.; Qiao C.; Liu Y.; Ding J.H.; Hu G.; Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation. Neurobiol Aging 2014,35(2),421-430","journal-title":"Neurobiol Aging"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2015.06.008","volume":"1622","author":"Liang Y.","year":"2015","unstructured":"Liang Y.; Jing X.; Zeng Z.; Bi W.; Chen Y.; Wu X.; Yang L.; Liu J.; Xiao S.; Liu S.; Lin D.; Tao E.; Rifampicin attenuates rotenone-induced inflammation via suppressing NLRP3 inflammasome activation in microglia. Brain Res 2015,1622,43-50","journal-title":"Brain Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s11064-017-2185-0","volume":"42","author":"Mao Z.","year":"2017","unstructured":"Mao Z.; Liu C.; Ji S.; Yang Q.; Ye H.; Han H.; Xue Z.; The NLRP3 inflammasome is involved in the pathogenesis of parkinson\u2019s disease in rats. Neurochem Res 2017,42(4),1104-1115","journal-title":"Neurochem Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"215","author":"Whitehouse P.J.","year":"1982","unstructured":"Whitehouse P.J.; Price D.L.; Struble R.G.; Clark A.W.; Coyle J.T.; Delon M.R.; Alzheimer\u2019s disease and senile dementia: Loss of neurons in the basal forebrain. Science 1982,215(4537),1237-1239","journal-title":"Science"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","volume":"129","author":"Liu A.K.","year":"2015","unstructured":"Liu A.K.; Chang R.C.; Pearce R.K.; Gentleman S.M.; Nucleus basalis of Meynert revisited: Anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease. Acta Neuropathol 2015,129(4),527-540","journal-title":"Acta Neuropathol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(85)90160-5","volume":"14","author":"Arendt T.","year":"1985","unstructured":"Arendt T.; Bigl V.; Tennstedt A.; Arendt A.; Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer\u2019s disease. Neuroscience 1985,14(1),1-14","journal-title":"Neuroscience"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3740461","volume":"2018","author":"Magalingam KB","year":"2018","unstructured":"Magalingam KB; Radhakrishnan A; Ping NS; Haleagrahara N; Current concepts of neurodegenerative mechanisms in alzheimer's disease. Biomed Res Int 2018,2018,1-12","journal-title":"Biomed Res Int"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"13249","DOI":"10.1038\/ncomms13249","volume":"7","author":"Schmitz T.W.","year":"2016","unstructured":"Schmitz T.W.; Nathan Spreng R.; Basal forebrain degeneration precedes and predicts the cortical spread of alzheimer\u2019s pathology. Nat Commun Alzheimer\u2019s disease neuroimaging initiative2016,7,13249","journal-title":"Nat Commun"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/14737175.2016.1204234","volume":"17","author":"Lista S.","year":"2017","unstructured":"Lista S.; Hampel H.; Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer\u2019s disease. Expert Rev Neurother 2017,17(1),47-57","journal-title":"Expert Rev Neurother"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/cercor\/bhn113","volume":"19","author":"Dickerson B.C.","year":"2009","unstructured":"Dickerson B.C.; Bakkour A.; Salat D.H.; Feczko E.; Pacheco J.; Greve D.N.; Grodstein F.; Wright C.I.; Blacker D.; Rosas H.D.; Sperling R.A.; Atri A.; Growdon J.H.; Hyman B.T.; Morris J.C.; Fischl B.; Buckner R.L.; The cortical signature of Alzheimer\u2019s disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 2009,19(3),497-510","journal-title":"Cereb Cortex"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"Sweeney M.D.","year":"2018","unstructured":"Sweeney M.D.; Sagare A.P.; Zlokovic B.V.; Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 2018,14(3),133-150","journal-title":"Nat Rev Neurol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1172\/JCI65053","volume":"122","author":"Sheng Z.","year":"2012","unstructured":"Sheng Z.; Oka S.; Tsuchimoto D.; Abolhassani N.; Nomaru H.; Sakumi K.; Yamada H.; Nakabeppu Y.; 8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair. J Clin Invest 2012,122(12),4344-4361","journal-title":"J Clin Invest"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"Heneka M.T.","year":"2015","unstructured":"Heneka M.T.; Carson M.J.; El Khoury J.; Landreth G.E.; Brosseron F.; Feinstein D.L.; Jacobs A.H.; Wyss-Coray T.; Vitorica J.; Ransohoff R.M.; Herrup K.; Frautschy S.A.; Finsen B.; Brown G.C.; Verkhratsky A.; Yamanaka K.; Koistinaho J.; Latz E.; Halle A.; Petzold G.C.; Town T.; Morgan D.; Shinohara M.L.; Perry V.H.; Holmes C.; Bazan N.G.; Brooks D.J.; Hunot S.; Joseph B.; Deigendesch N.; Garaschuk O.; Boddeke E.; Dinarello C.A.; Breitner J.C.; Cole G.M.; Golenbock D.T.; Kummer M.P.; Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 2015,14(4),388-405","journal-title":"Lancet Neurol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","volume":"22","author":"Mrak R.E.","year":"2001","unstructured":"Mrak R.E.; Griffin W.S.; Interleukin-1, neuroinflammation, and Alzheimer\u2019s disease. Neurobiol Aging 2001,22(6),903-908","journal-title":"Neurobiol Aging"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neurobiolaging.2007.06.006","volume":"30","author":"Ojala J.","year":"2009","unstructured":"Ojala J.; Alafuzoff I.; Herukka S.K.; van Groen T.; Tanila H.; Pirttil\u00e4 T.; Expression of interleukin-18 is increased in the brains of Alzheimer\u2019s disease patients. Neurobiol Aging 2009,30(2),198-209","journal-title":"Neurobiol Aging"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","volume":"68","author":"Sayre L.M.","year":"1997","unstructured":"Sayre L.M.; Zelasko D.A.; Harris P.L.; Perry G.; Salomon R.G.; Smith M.A.; 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer\u2019s disease. J Neurochem 1997,68(5),2092-2097","journal-title":"J Neurochem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0197-4580(00)00235-9","volume":"22","author":"Lovell M.A.","year":"2001","unstructured":"Lovell M.A.; Xie C.; Markesbery W.R.; Acrolein is increased in Alzheimer\u2019s disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 2001,22(2),187-194","journal-title":"Neurobiol Aging"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.neurobiolaging.2010.08.016","volume":"33","author":"Bradley M.A.","year":"2012","unstructured":"Bradley M.A.; Xiong-Fister S.; Markesbery W.R.; Lovell M.A.; Elevated 4-hydroxyhexenal in Alzheimer\u2019s disease (AD) progression. Neurobiol Aging 2012,33(6),1034-1044","journal-title":"Neurobiol Aging"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","volume":"30","author":"Chen Z.","year":"2014","unstructured":"Chen Z.; Zhong C.; Oxidative stress in Alzheimer\u2019s disease. Neurosci Bull 2014,30(2),271-281","journal-title":"Neurosci Bull"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2018.01.059","volume":"405","author":"Simon E.","year":"2019","unstructured":"Simon E.; Obst J.; Gomez-Nicola D.; The evolving dialogue of microglia and neurons in alzheimer\u2019s disease: Microglia as necessary transducers of pathology. Neuroscience 2019,405,24-34","journal-title":"Neuroscience"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"Montagne A.","year":"2015","unstructured":"Montagne A.; Barnes S.R.; Sweeney M.D.; Halliday M.R.; Sagare A.P.; Zhao Z.; Toga A.W.; Jacobs R.E.; Liu C.Y.; Amezcua L.; Harrington M.G.; Chui H.C.; Law M.; Zlokovic B.V.; Blood-brain barrier breakdown in the aging human hippocampus. Neuron 2015,85(2),296-302","journal-title":"Neuron"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","volume":"49","author":"Simard A.R.","year":"2006","unstructured":"Simard A.R.; Soulet D.; Gowing G.; Julien J.P.; Rivest S.; Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease. Neuron 2006,49(4),489-502","journal-title":"Neuron"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3109\/00207454.2013.833510","volume":"124","author":"Cai Z.","year":"2014","unstructured":"Cai Z.; Hussain M.D.; Yan L.J.; Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer\u2019s disease. Int J Neurosci 2014,124(5),307-321","journal-title":"Int J Neurosci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0140-6736(11)60830-1","volume":"378","author":"Banerjee S.","year":"2011","unstructured":"Banerjee S.; Hellier J.; Dewey M.; Romeo R.; Ballard C.; Baldwin R.; Bentham P.; Fox C.; Holmes C.; Katona C.; Knapp M.; Lawton C.; Lindesay J.; Livingston G.; McCrae N.; Moniz-Cook E.; Murray J.; Nurock S.; Orrell M.; O\u2019Brien J.; Poppe M.; Thomas A.; Walwyn R.; Wilson K.; Burns A.; Sertraline or mirtazapine for depression in dementia (HTA-SADD): A randomised, multicentre, double-blind, placebo-controlled trial. Lancet 2011,378(9789),403-411","journal-title":"Lancet"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.nicl.2013.06.004","volume":"2","author":"Garraux G.","year":"2013","unstructured":"Garraux G.; Phillips C.; Schrouff J.; Kreisler A.; Lemaire C.; Degueldre C.; Delcour C.; Hustinx R.; Luxen A.; Dest\u00e9e A.; Salmon E.; Multiclass classification of FDG PET scans for the distinction between Parkinson\u2019s disease and atypical parkinsonian syndromes. Neuroimage Clin 2013,2,883-893","journal-title":"Neuroimage Clin"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphar.2012.00014","volume":"3","author":"Solito E.","year":"2012","unstructured":"Solito E.; Sastre M.; Microglia function in Alzheimer\u2019s disease. Front Pharmacol 2012,3,14","journal-title":"Front Pharmacol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1182\/blood-2003-10-3536","volume":"104","author":"Rouhiainen A.","year":"2004","unstructured":"Rouhiainen A.; Kuja-Panula J.; Wilkman E.; Pakkanen J.; Stenfors J.; Tuominen R.K.; Lep\u00e4ntalo M.; Carp\u00e9n O.; Parkkinen J.; Rauvala H.; Regulation of monocyte migration by amphoterin (HMGB1). Blood 2004,104(4),1174-1182","journal-title":"Blood"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"Halle A.","year":"2008","unstructured":"Halle A.; Hornung V.; Petzold G.C.; Stewart C.R.; Monks B.G.; Reinheckel T.; Fitzgerald K.A.; Latz E.; Moore K.J.; Golenbock D.T.; The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2. Nat Immunol 2008,9(8),857-865","journal-title":"Nat Immunol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"Heneka M.T.","year":"2013","unstructured":"Heneka M.T.; Kummer M.P.; Stutz A.; Delekate A.; Schwartz S.; Vieira-Saecker A.; Griep A.; Axt D.; Remus A.; Tzeng T.C.; Gelpi E.; Halle A.; Korte M.; Latz E.; Golenbock D.T.; NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 2013,493(7434),674-678","journal-title":"Nature"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s12035-013-8475-x","volume":"48","author":"Tan M.S.","year":"2013","unstructured":"Tan M.S.; Yu J.T.; Jiang T.; Zhu X.C.; Tan L.; The NLRP3 inflammasome in Alzheimer\u2019s disease. Mol Neurobiol 2013,48(3),875-882","journal-title":"Mol Neurobiol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","volume":"74","author":"Tarkowski E.","year":"2003","unstructured":"Tarkowski E.; Andreasen N.; Tarkowski A.; Blennow K.; Intrathecal inflammation precedes development of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 2003,74(9),1200-1205","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.neuroimage.2011.05.012","volume":"57","author":"Takahashi T.","year":"2011","unstructured":"Takahashi T.; Takikawa Y.; Kawagoe R.; Shibuya S.; Iwano T.; Kitazawa S.; Influence of skin blood flow on near-infrared spectroscopy signals measured on the forehead during a verbal fluency task. Neuroimage 2011,57(3),991-1002","journal-title":"Neuroimage"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"Ising C.","year":"2019","unstructured":"Ising C.; Venegas C.; Zhang S.; Scheiblich H.; Schmidt S.V.; Vieira-Saecker A.; Schwartz S.; Albasset S.; McManus R.M.; Tejera D.; Griep A.; Santarelli F.; Brosseron F.; Opitz S.; Stunden J.; Merten M.; Kayed R.; Golenbock D.T.; Blum D.; Latz E.; Bu\u00e9e L.; Heneka M.T.; NLRP3 inflammasome activation drives tau pathology. Nature 2019,575(7784),669-673","journal-title":"Nature"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"Franceschi C.","year":"2000","unstructured":"Franceschi C.; Bonaf\u00e8 M.; Valensin S.; Olivieri F.; De Luca M.; Ottaviani E.; De Benedictis G.; Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000,908(1),244-254","journal-title":"Ann N Y Acad Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10522-017-9682-z","volume":"18","author":"Pawelec G.","year":"2017","unstructured":"Pawelec G.; Immunosenescence and cancer. Biogerontology 2017,18(4),717-721","journal-title":"Biogerontology"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6039171","volume":"2018","author":"Costantini E.","year":"2018","unstructured":"Costantini E.; D\u2019Angelo C.; Reale M.; The role of immunosenescence in neurodegenerative diseases Mediators Inflamm 2018,2018,1-12","journal-title":"The role of immunosenescence in neurodegenerative diseases Mediators Inflamm"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.bbabio.2015.04.010","volume":"1847","author":"Lionaki E.","year":"2015","unstructured":"Lionaki E.; Markaki M.; Palikaras K.; Tavernarakis N.; Mitochondria, autophagy and age-associated neurodegenerative diseases: New insights into a complex interplay. Biochim Biophys Acta 2015,1847(11),1412-1423","journal-title":"Biochim Biophys Acta"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"L\u00f3pez-Ot\u00edn C.","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn C.; Blasco M.A.; Partridge L.; Serrano M.; Kroemer G.; The hallmarks of aging. Cell 2013,153(6),1194-1217","journal-title":"Cell"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/gerona\/glw240","volume":"72","author":"Foug\u00e8re B.","year":"2017","unstructured":"Foug\u00e8re B.; Boulanger E.; Nourhash\u00e9mi F.; Guyonnet S.; Cesari M.; Chronic inflammation: Accelerator of biological aging. J Gerontol A Biol Sci Med Sci 2017,72(9),1218-1225","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=92","first-page":"229","volume":"5","author":"Poewe W.","year":"2010","unstructured":"Poewe W.; Antonini A.; Zijlmans J.C.; Burkhard P.R.; Vingerhoets F.; Levodopa in the treatment of Parkinson\u2019s disease: An old drug still going strong. Clin Interv Aging 2010,5,229-238","journal-title":"Clin Interv Aging"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","volume":"14","author":"Moussa C.","year":"2017","unstructured":"Moussa C.; Hebron M.; Huang X.; Ahn J.; Rissman R.A.; Aisen P.S.; Turner R.S.; Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease. J Neuroinflammation 2017,14(1),1","journal-title":"J Neuroinflammation"},{"key":"ref=94","first-page":"1527","volume":"60","author":"Bortolato M","year":"2008","unstructured":"Bortolato M; Chen K; Monoamine oxidase inactivation: From pathophysiology to therapeutics. 2008,60(13-14),1527-33"},{"key":"ref=95","first-page":"109","volume":"86","author":"CAJBmb Davie","year":"2008","unstructured":"CAJBmb Davie; A review of Parkinson's disease 2008,86(1),109-27","journal-title":"A review of Parkinson's disease"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/S1353-8020(09)70835-1","volume":"15","author":"Bonuccelli U.","year":"2009","unstructured":"Bonuccelli U.; Del Dotto P.; Rascol O.; Role of dopamine receptor agonists in the treatment of early Parkinson\u2019s disease. Parkinsonism Relat Disord 2009,15(Suppl. 4),S44-S53","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuroscience.2012.02.001","volume":"208","author":"Gillardon F.","year":"2012","unstructured":"Gillardon F.; Schmid R.; Draheim H.; Parkinson\u2019s disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity. Neuroscience 2012,208,41-48","journal-title":"Neuroscience"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1084\/jem.20170014","volume":"214","author":"Liu W.","year":"2017","unstructured":"Liu W.; Liu X.; Li Y.; Zhao J.; Liu Z.; Hu Z.; Wang Y.; Yao Y.; Miller A.W.; Su B.; Cookson M.R.; Li X.; Kang Z.; LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection. J Exp Med 2017,214(10),3051-3066","journal-title":"J Exp Med"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","volume":"109","author":"Yang L.","year":"2009","unstructured":"Yang L.; Calingasan N.Y.; Wille E.J.; Cormier K.; Smith K.; Ferrante R.J.; Beal M.F.; Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson\u2019s and Huntington\u2019s diseases. J Neurochem 2009,109(5),1427-1439","journal-title":"J Neurochem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/07853890.2017.1293285","volume":"49","author":"Chang Y.","year":"2017","unstructured":"Chang Y.; Wang L.B.; Li D.; Lei K.; Liu S.Y.; Efficacy of rasagiline for the treatment of Parkinson\u2019s disease: An updated meta-analysis. Ann Med 2017,49(5),421-434","journal-title":"Ann Med"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/WNF.0b013e3181342f32","volume":"31","year":"2008","unstructured":"A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results. Clin Neuropharmacol NINDS NET-PD Investigators2008,31(3),141-150","journal-title":"Clin Neuropharmacol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/mds.27738","volume":"34","author":"Brys M.","year":"2019","unstructured":"Brys M.; Fanning L.; Hung S.; Ellenbogen A.; Penner N.; Yang M.; Welch M.; Koenig E.; David E.; Fox T.; Makh S.; Aldred J.; Goodman I.; Pepinsky B.; Liu Y.; Graham D.; Weihofen A.; Cedarbaum J.M.; Randomized phase I clinical trial of anti-\u03b1-synuclein antibody BIIB054. Mov Disord 2019,34(8),1154-1163","journal-title":"Mov Disord"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/nan.12312","volume":"42","author":"Valera E.","year":"2016","unstructured":"Valera E.; Monzio Compagnoni G.; Masliah E.; Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy. Neuropathol Appl Neurobiol 2016,42(1),95-106","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/070674371506000712","volume":"60","author":"Hogan D.B.","year":"2015","unstructured":"Hogan D.B.; Re: Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of alzheimer disease. Can J Psychiatry 2015,60(7),338","journal-title":"Can J Psychiatry"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","volume":"70","author":"Reger M.A.","year":"2008","unstructured":"Reger M.A.; Watson G.S.; Green P.S.; Wilkinson C.W.; Baker L.D.; Cholerton B.; Fishel M.A.; Plymate S.R.; Breitner J.C.; DeGroodt W.; Mehta P.; Craft S.; Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 2008,70(6),440-448","journal-title":"Neurology"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"Craft S.","year":"2012","unstructured":"Craft S.; Baker L.D.; Montine T.J.; Minoshima S.; Watson G.S.; Claxton A.; Arbuckle M.; Callaghan M.; Tsai E.; Plymate S.R.; Green P.S.; Leverenz J.; Cross D.; Gerton B.; Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial. Arch Neurol 2012,69(1),29-38","journal-title":"Arch Neurol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1517\/14656566.2014.936848","volume":"15","author":"Broadstock M.","year":"2014","unstructured":"Broadstock M.; Ballard C.; Corbett A.; Latest treatment options for Alzheimer\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies. Expert Opin Pharmacother 2014,15(13),1797-1810","journal-title":"Expert Opin Pharmacother"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"Honig L.S.","year":"2018","unstructured":"Honig L.S.; Vellas B.; Woodward M.; Boada M.; Bullock R.; Borrie M.; Hager K.; Andreasen N.; Scarpini E.; Liu-Seifert H.; Case M.; Dean R.A.; Hake A.; Sundell K.; Poole Hoffmann V.; Carlson C.; Khanna R.; Mintun M.; DeMattos R.; Selzler K.J.; Siemers E.; Trial of solanezumab for mild dementia due to alzheimer\u2019s disease. N Engl J Med 2018,378(4),321-330","journal-title":"N Engl J Med"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/emmm.201101084","volume":"4","author":"Cai J.","year":"2012","unstructured":"Cai J.; Qi X.; Kociok N.; Skosyrski S.; Emilio A.; Ruan Q.; Han S.; Liu L.; Chen Z.; Bowes Rickman C.; Golde T.; Grant M.B.; Saftig P.; Serneels L.; de Strooper B.; Joussen A.M.; Boulton M.E.; \u03b2-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment. EMBO Mol Med 2012,4(9),980-991","journal-title":"EMBO Mol Med"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archneur.65.8.1031","volume":"65","author":"Fleisher A.S.","year":"2008","unstructured":"Fleisher A.S.; Raman R.; Siemers E.R.; Becerra L.; Clark C.M.; Dean R.A.; Farlow M.R.; Galvin J.E.; Peskind E.R.; Quinn J.F.; Sherzai A.; Sowell B.B.; Aisen P.S.; Thal L.J.; Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Arch Neurol 2008,65(8),1031-1038","journal-title":"Arch Neurol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/archneurol.2012.85","volume":"69","author":"Galasko D.R.","year":"2012","unstructured":"Galasko D.R.; Peskind E.; Clark C.M.; Quinn J.F.; Ringman J.M.; Jicha G.A.; Cotman C.; Cottrell B.; Montine T.J.; Thomas R.G.; Aisen P.; Antioxidants for alzheimer disease: A randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol Alzheimer\u2019s disease cooperative study2012,69(7),836-841","journal-title":"Arch Neurol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","volume":"28","author":"Baum L.","year":"2008","unstructured":"Baum L.; Lam C.W.; Cheung S.K.; Kwok T.; Lui V.; Tsoh J.; Lam L.; Leung V.; Hui E.; Ng C.; Woo J.; Chiu H.F.; Goggins W.B.; Zee B.C.; Cheng K.F.; Fong C.Y.; Wong A.; Mok H.; Chow M.S.; Ho P.C.; Ip S.P.; Ho C.S.; Yu X.W.; Lai C.Y.; Chan M.H.; Szeto S.; Chan I.H.; Mok V.; Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 2008,28(1),110-113","journal-title":"J Clin Psychopharmacol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1001\/jama.2009.1913","volume":"302","author":"Snitz B.E.","year":"2009","unstructured":"Snitz B.E.; O\u2019Meara E.S.; Carlson M.C.; Arnold A.M.; Ives D.G.; Rapp S.R.; Saxton J.; Lopez O.L.; Dunn L.O.; Sink K.M.; DeKosky S.T.; Ginkgo biloba for preventing cognitive decline in older adults: A randomized trial. JAMA Ginkgo evaluation of memory (GEM) study investigators2009,302(24),2663-2670","journal-title":"JAMA"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1471-4159.2004.02743.x","volume":"91","author":"Gasparini L.","year":"2004","unstructured":"Gasparini L.; Ongini E.; Wenk G.; Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer\u2019s disease: Old and new mechanisms of action. J Neurochem 2004,91(3),521-536","journal-title":"J Neurochem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1212\/WNL.45.8.1441","volume":"45","author":"Andersen K.","year":"1995","unstructured":"Andersen K.; Launer L.J.; Ott A.; Hoes A.W.; Breteler M.M.; Hofman A.; Do nonsteroidal anti-inflammatory drugs decrease the risk for alzheimer\u2019s disease? the rotterdam study. Neurology 1995,45(8),1441-1445","journal-title":"Neurology"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.brainres.2013.10.025","volume":"1541","author":"Carreras I.","year":"2013","unstructured":"Carreras I.; McKee A.C.; Choi J.K.; Aytan N.; Kowall N.W.; Jenkins B.G.; Dedeoglu A.; R-flurbiprofen improves tau, but not A\u00df pathology in a triple transgenic model of Alzheimer\u2019s disease. Brain Res 2013,1541,115-127","journal-title":"Brain Res"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000096588","volume":"23","author":"Soininen H.","year":"2007","unstructured":"Soininen H.; West C.; Robbins J.; Niculescu L.; Long-term efficacy and safety of celecoxib in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 2007,23(1),8-21","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","volume":"30","author":"Thal L.J.","year":"2005","unstructured":"Thal L.J.; Ferris S.H.; Kirby L.; Block G.A.; Lines C.R.; Yuen E.; Assaid C.; Nessly M.L.; Norman B.A.; Baranak C.C.; Reines S.A.; A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology Rofecoxib Protocol 078 study group2005,30(6),1204-1215","journal-title":"Neuropsychopharmacology"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","volume":"7","author":"Lyketsos C.G.","year":"2011","unstructured":"Lyketsos C.G.; Carrillo M.C.; Ryan J.M.; Khachaturian A.S.; Trzepacz P.; Amatniek J.; Cedarbaum J.; Brashear R.; Miller D.S.; Neuropsychiatric symptoms in Alzheimer\u2019s disease. Alzheimers Dement 2011,7(5),532-539","journal-title":"Alzheimers Dement"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/BF03325217","volume":"21","author":"Pasqualetti P.","year":"2009","unstructured":"Pasqualetti P.; Bonomini C.; Dal Forno G.; Paulon L.; Sinforiani E.; Marra C.; Zanetti O.; Rossini P.M.; A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer\u2019s disease. Aging Clin Exp Res 2009,21(2),102-110","journal-title":"Aging Clin Exp Res"},{"key":"ref=121","first-page":"149","volume":"5","author":"Burstein A.H.","year":"2018","unstructured":"Burstein A.H.; Sabbagh M.; Andrews R.; Valcarce C.; Dunn I.; Altstiel L.; Development of azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild alzheimer\u2019s disease. J Prev Alzheimers Dis 2018,5(2),149-154","journal-title":"J Prev Alzheimers Dis"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"Jonsson T.","year":"2013","unstructured":"Jonsson T.; Stefansson H.; Steinberg S.; Jonsdottir I.; Jonsson P.V.; Snaedal J.; Bjornsson S.; Huttenlocher J.; Levey A.I.; Lah J.J.; Rujescu D.; Hampel H.; Giegling I.; Andreassen O.A.; Engedal K.; Ulstein I.; Djurovic S.; Ibrahim-Verbaas C.; Hofman A.; Ikram M.A.; van Duijn C.M.; Thorsteinsdottir U.; Kong A.; Stefansson K.; Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 2013,368(2),107-116","journal-title":"N Engl J Med"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"Leyns C.E.G.","year":"2017","unstructured":"Leyns C.E.G.; Ulrich J.D.; Finn M.B.; Stewart F.R.; Koscal L.J.; Remolina Serrano J.; Robinson G.O.; Anderson E.; Colonna M.; Holtzman D.M.; TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci USA 2017,114(43),11524-11529","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"E8788","DOI":"10.1073\/pnas.1714175114","volume":"114","author":"Ofengeim D.","year":"2017","unstructured":"Ofengeim D.; Mazzitelli S.; Ito Y.; DeWitt J.P.; Mifflin L.; Zou C.; Das S.; Adiconis X.; Chen H.; Zhu H.; Kelliher M.A.; Levin J.Z.; Yuan J.; RIPK1 mediates a disease-associated microglial response in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 2017,114(41),E8788-E8797","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1468-1331.2010.03303.x","volume":"8","author":"Jellinger K.A.","year":"2011","unstructured":"Jellinger K.A.; Atlas of Epilepsies. Eur J Neurol 2011,8(18),105","journal-title":"Eur J Neurol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.pain.2007.08.028","volume":"133","author":"Nurmikko T.J.","year":"2007","unstructured":"Nurmikko T.J.; Serpell M.G.; Hoggart B.; Toomey P.J.; Morlion B.J.; Haines D.; Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial. Pain 2007,133(1-3),210-220","journal-title":"Pain"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1021\/jf800898p","volume":"56","author":"Pezzuto J.M.","year":"2008","unstructured":"Pezzuto J.M.; Grapes and human health: A perspective. J Agric Food Chem 2008,56(16),6777-6784","journal-title":"J Agric Food Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.bbadis.2014.10.006","volume":"1852","author":"Pasinetti G.M.","year":"2015","unstructured":"Pasinetti G.M.; Wang J.; Ho L.; Zhao W.; Dubner L.; Roles of resveratrol and other grape-derived polyphenols in Alzheimer\u2019s disease prevention and treatment. Biochim Biophys Acta 2015,1852(6),1202-1208","journal-title":"Biochim Biophys Acta"},{"key":"ref=129","first-page":"180","volume":"85","author":"Youdim KA","year":"2003","unstructured":"Youdim KA; Dobbie MS; Kuhnle G; Proteggente AR; Abbott NJ; Interaction between flavonoids and the blood\u2013brain barrier: In vitro studies. 2003,85(1),180-92"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0378-4347(98)00204-7","volume":"714","author":"Peng H","year":"1998","unstructured":"Peng H; Cheng F; Huang Y; Chen C; Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998,714(2),369-374","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"ref=131","first-page":"331","volume":"8","author":"Tsai T","year":"2000","unstructured":"Tsai T; Determination of unbound hesperetin in rat blood and brain by microdialysis coupled to microbore liquid chromatography. Analysis D 2000,8(4),331-6","journal-title":"Analysis D"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1021\/jf071998l","volume":"56","author":"McDonald JE","year":"2008","unstructured":"McDonald JE; Fillmore SA; Graf BA; Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. J Agric Food Chem 2008,56(3),705-712","journal-title":"J Agric Food Chem"},{"key":"ref=133","author":"Pfleger CM","year":"2010","unstructured":"Pfleger CM; Wang J; Friedman L; Vittorino R; Conley LM; Ho L; Wang J; Grape-seed polyphenolic extract improves the eye phenotype in a drosophila model of tauopathy. Int J Alzheimers Dis 2010","journal-title":"Int J Alzheimers Dis"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.neurobiolaging.2011.09.027","volume":"33","author":"Santa-Maria I.","year":"2012","unstructured":"Santa-Maria I.; Diaz-Ruiz C.; Ksiezak-Reding H.; Chen A.; Ho L.; Wang J.; Pasinetti G.M.; GSPE interferes with tau aggregation in vivo: Implication for treating tauopathy. Neurobiol Aging 2012,33(9),2072-2081","journal-title":"Neurobiol Aging"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3233\/JAD-2010-101074","volume":"22","author":"Wang J.","year":"2010","unstructured":"Wang J.; Santa-Maria I.; Ho L.; Ksiezak-Reding H.; Ono K.; Teplow D.B.; Pasinetti G.M.; Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 2010,22(2),653-661","journal-title":"J Alzheimers Dis"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/mnfr.201400370","volume":"59","author":"Martinez-Micaelo N.","year":"2015","unstructured":"Martinez-Micaelo N.; Gonz\u00e1lez-Abu\u00edn N.; Pinent M.; Ard\u00e9vol A.; Blay M.; Procyanidin B2 inhibits inflammasome-mediated IL-1\u03b2 production in lipopolysaccharide-stimulated macrophages. Mol Nutr Food Res 2015,59(2),262-269","journal-title":"Mol Nutr Food Res"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/mnfr.201100262","volume":"55","author":"Kim M.J.","year":"2011","unstructured":"Kim M.J.; Seong A.R.; Yoo J.Y.; Jin C.H.; Lee Y.H.; Kim Y.J.; Lee J.; Jun W.J.; Yoon H.G.; Gallic acid, a histone acetyltransferase inhibitor, suppresses \u03b2-amyloid neurotoxicity by inhibiting microglial-mediated neuroinflammation. Mol Nutr Food Res 2011,55(12),1798-1808","journal-title":"Mol Nutr Food Res"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1016\/j.bmcl.2013.09.071","volume":"23","author":"Liu Y.","year":"2013","unstructured":"Liu Y.; Pukala T.L.; Musgrave I.F.; Williams D.M.; Dehle F.C.; Carver J.A.; Gallic acid is the major component of grape seed extract that inhibits amyloid fibril formation. Bioorg Med Chem Lett 2013,23(23),6336-6340","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.1074\/jbc.M508246200","volume":"280","author":"Marambaud P.","year":"2005","unstructured":"Marambaud P.; Zhao H.; Davies P.; Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-beta peptides. J Biol Chem 2005,280(45),37377-37382","journal-title":"J Biol Chem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.fct.2013.07.021","volume":"61","author":"Carrizzo A.","year":"2013","unstructured":"Carrizzo A.; Forte M.; Damato A.; Trimarco V.; Salzano F.; Bartolo M.; Maciag A.; Puca A.A.; Vecchione C.; Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases. Food Chem Toxicol 2013,61,215-226","journal-title":"Food Chem Toxicol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.intimp.2004.08.008","volume":"5","author":"Bi X.L.","year":"2005","unstructured":"Bi X.L.; Yang J.Y.; Dong Y.X.; Wang J.M.; Cui Y.H.; Ikeshima T.; Zhao Y.Q.; Wu C.F.; Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol 2005,5(1),185-193","journal-title":"Int Immunopharmacol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.neuroscience.2018.03.047","volume":"379","author":"Zhao H.","year":"2018","unstructured":"Zhao H.; Wang Q.; Cheng X.; Li X.; Li N.; Liu T.; Li J.; Yang Q.; Dong R.; Zhang Y.; Zhang L.; Inhibitive effect of resveratrol on the inflammation in cultured astrocytes and microglia induced by A\u03b2. Neuroscience 2018,379,390-404","journal-title":"Neuroscience"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3177\/jnsv.52.33","volume":"52","author":"Rho K.A.","year":"2006","unstructured":"Rho K.A.; Kim M.K.; Effects of different grape formulations on antioxidative capacity, lipid peroxidation and oxidative DNA damage in aged rats. J Nutr Sci Vitaminol (Tokyo) 2006,52(1),33-46","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/FBP.0000000000000276","volume":"28","author":"Chen C","year":"2017","unstructured":"Chen C; Zheng Y; Wu T; Wu C; Cheng X.; Oral administration of grape seed polyphenol extract restores memory deficits in chronic cerebral hypoperfusion rats. Behav Pharmacol 2017,28(2, 3),207-13","journal-title":"Behav Pharmacol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jnutbio.2016.04.006","volume":"34","author":"Chou L.M.","year":"2016","unstructured":"Chou L.M.; Lin C.I.; Chen Y.H.; Liao H.; Lin S.H.; A diet containing grape powder ameliorates the cognitive decline in aged rats with a long-term high-fructose-high-fat dietary pattern. J Nutr Biochem 2016,34,52-60","journal-title":"J Nutr Biochem"},{"key":"ref=146","first-page":"25","volume":"13","author":"Yamakoshi J.","year":"2001","unstructured":"Yamakoshi J.; Tokutake S.; Kikuchi M.; Kubota Y.; Konishi H.; Mitsuoka T.; Effect of proanthocyanidin-rich extract from grape seeds on human fecal flora and fecal odor. Microb Ecol Health Dis 2001,13(1),25-31","journal-title":"Microb Ecol Health Dis"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.00018.2001","volume":"82","author":"Dr\u00f6ge W.","year":"2002","unstructured":"Dr\u00f6ge W.; Free radicals in the physiological control of cell function. Physiol Rev 2002,82(1),47-95","journal-title":"Physiol Rev"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12013-009-9043-x","volume":"53","author":"Perron N.R.","year":"2009","unstructured":"Perron N.R.; Brumaghim J.L.; A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys 2009,53(2),75-100","journal-title":"Cell Biochem Biophys"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"Zhou R.","year":"2011","unstructured":"Zhou R.; Yazdi A.S.; Menu P.; Tschopp J.; A role for mitochondria in NLRP3 inflammasome activation. Nature 2011,469(7329),221-225","journal-title":"Nature"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1211\/jpp.59.12.0010","volume":"59","author":"Foti M.C.","year":"2007","unstructured":"Foti M.C.; Antioxidant properties of phenols. J Pharm Pharmacol 2007,59(12),1673-1685","journal-title":"J Pharm Pharmacol"},{"key":"ref=151","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9783429","author":"Bungau S","year":"2019","unstructured":"Bungau S; Abdel-Daim MM; Tit DM; Health benefits of polyphenols and carotenoids in age-related eye diseases. Oxid Med Cell Longev 2019","journal-title":"Oxid Med Cell Longev"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/10715769509145649","volume":"22","author":"Rice-Evans C.A.","year":"1995","unstructured":"Rice-Evans C.A.; Miller N.J.; Bolwell P.G.; Bramley P.M.; Pridham J.B.; The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 1995,22(4),375-383","journal-title":"Free Radic Res"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"He Y.","year":"2016","unstructured":"He Y.; Hara H.; N\u00fa\u00f1ez G.; Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci 2016,41(12),1012-1021","journal-title":"Trends Biochem Sci"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbi.2018.06.010","volume":"73","author":"Herman F.J.","year":"2018","unstructured":"Herman F.J.; Pasinetti G.M.; Principles of inflammasome priming and inhibition: Implications for psychiatric disorders. Brain Behav Immun 2018,73,66-84","journal-title":"Brain Behav Immun"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"Garlanda C.","year":"2013","unstructured":"Garlanda C.; Dinarello C.A.; Mantovani A.; The interleukin-1 family: Back to the future. Immunity 2013,39(6),1003-1018","journal-title":"Immunity"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature10234","volume":"476","author":"Baughman J.M.","year":"2011","unstructured":"Baughman J.M.; Perocchi F.; Girgis H.S.; Plovanich M.; Belcher-Timme C.A.; Sancak Y.; Bao X.R.; Strittmatter L.; Goldberger O.; Bogorad R.L.; Koteliansky V.; Mootha V.K.; Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 2011,476(7360),341-345","journal-title":"Nature"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.neurobiolaging.2015.05.018","volume":"36","author":"Chen L.","year":"2015","unstructured":"Chen L.; Na R.; Boldt E.; Ran Q.; NLRP3 inflammasome activation by mitochondrial reactive oxygen species plays a key role in long-term cognitive impairment induced by paraquat exposure. Neurobiol Aging 2015,36(9),2533-2543","journal-title":"Neurobiol Aging"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bbi.2009.10.002","volume":"24","author":"Hein A.M.","year":"2010","unstructured":"Hein A.M.; Stasko M.R.; Matousek S.B.; Scott-McKean J.J.; Maier S.F.; Olschowka J.A.; Costa A.C.; O\u2019Banion M.K.; Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice. Brain Behav Immun 2010,24(2),243-253","journal-title":"Brain Behav Immun"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.neuroscience.2009.08.073","volume":"164","author":"Moore A.H.","year":"2009","unstructured":"Moore A.H.; Wu M.; Shaftel S.S.; Graham K.A.; O\u2019Banion M.K.; Sustained expression of interleukin-1beta in mouse hippocampus impairs spatial memory. Neuroscience 2009,164(4),1484-1495","journal-title":"Neuroscience"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3389\/fnins.2017.00611","volume":"11","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; Wu Q.; Zhang Q.; Lu Y.; Liu J.; Li W.; Lv S.; Zhou M.; Zhang X.; Hang C.; Resveratrol attenuates early brain injury after experimental subarachnoid hemorrhage via inhibition of NLRP3 inflammasome activation. Front Neurosci 2017,11,611","journal-title":"Front Neurosci"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/intimm\/dxv018","volume":"27","author":"Misawa T.","year":"2015","unstructured":"Misawa T.; Saitoh T.; Kozaki T.; Park S.; Takahama M.; Akira S.; Resveratrol inhibits the acetylated \u03b1-tubulin-mediated assembly of the NLRP3-inflammasome. Int Immunol 2015,27(9),425-434","journal-title":"Int Immunol"},{"key":"ref=162","first-page":"3212","volume":"17","author":"Zou P.","year":"2018","unstructured":"Zou P.; Liu X.; Li G.; Wang Y.; Resveratrol pretreatment attenuates traumatic brain injury in rats by suppressing NLRP3 inflammasome activation via SIRT1. Mol Med Rep 2018,17(2),3212-3217","journal-title":"Mol Med Rep"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.jid.2017.05.019","volume":"137","author":"Xue J.","year":"2017","unstructured":"Xue J.; Yu C.; Sheng W.; Zhu W.; Luo J.; Zhang Q.; Yang H.; Cao H.; Wang W.; Zhou J.; Wu J.; Cao P.; Chen M.; Ding W.Q.; Cao J.; Zhang S.; The Nrf2\/GCH1\/BH4 axis ameliorates radiation-induced skin injury by modulating the ROS cascade. J Invest Dermatol 2017,137(10),2059-2068","journal-title":"J Invest Dermatol"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10787-017-0356-x","volume":"25","author":"Ruiz-Miyazawa K.W.","year":"2017","unstructured":"Ruiz-Miyazawa K.W.; Staurengo-Ferrari L.; Mizokami S.S.; Domiciano T.P.; Vicentini F.T.M.C.; Camilios-Neto D.; Pavanelli W.R.; Pinge-Filho P.; Amaral F.A.; Teixeira M.M.; Casagrande R.; Verri W.A.; Quercetin inhibits gout arthritis in mice: Induction of an opioid-dependent regulation of inflammasome. Inflammopharmacology 2017,25,555-570","journal-title":"Inflammopharmacology"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"7343","DOI":"10.1021\/acs.jafc.5b02605","volume":"63","author":"Jhang J.J.","year":"2015","unstructured":"Jhang J.J.; Lu C.C.; Ho C.Y.; Cheng Y.T.; Yen G.C.; Protective effects of catechin against monosodium urate-induced inflammation through the modulation of NLRP3 inflammasome activation. J Agric Food Chem 2015,63(33),7343-7352","journal-title":"J Agric Food Chem"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.intimp.2017.11.013","volume":"54","author":"Yang Y.","year":"2018","unstructured":"Yang Y.; Zhang X.; Xu M.; Wu X.; Zhao F.; Zhao C.; Quercetin attenuates collagen-induced arthritis by restoration of Th17\/Treg balance and activation of Heme Oxygenase 1-mediated anti-inflammatory effect. Int Immunopharmacol 2018,54,153-162","journal-title":"Int Immunopharmacol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/sc.2015.227","volume":"54","author":"Jiang W.","year":"2016","unstructured":"Jiang W.; Huang Y.; Han N.; He F.; Li M.; Bian Z.; Liu J.; Sun T.; Zhu L.; Quercetin suppresses NLRP3 inflammasome activation and attenuates histopathology in a rat model of spinal cord injury. Spinal Cord 2016,54(8),592-596","journal-title":"Spinal Cord"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/bph.12226","volume":"169","author":"Wang W.","year":"2013","unstructured":"Wang W.; Wang C.; Ding X.Q.; Pan Y.; Gu T.T.; Wang M.X.; Liu Y.L.; Wang F.M.; Wang S.J.; Kong L.D.; Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats. Br J Pharmacol 2013,169(6),1352-1371","journal-title":"Br J Pharmacol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/cns.12983","volume":"24","author":"Feng J.","year":"2018","unstructured":"Feng J.; Wang J.X.; Du Y.H.; Liu Y.; Zhang W.; Chen J.F.; Liu Y.J.; Zheng M.; Wang K.J.; He G.Q.; Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP\/PS1 transgenic mice. CNS Neurosci Ther 2018,24(12),1207-1218","journal-title":"CNS Neurosci Ther"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00018-008-7461-3","volume":"65","author":"Salminen A.","year":"2008","unstructured":"Salminen A.; Ojala J.; Huuskonen J.; Kauppinen A.; Suuronen T.; Kaarniranta K.; Interaction of aging-associated signaling cascades: Inhibition of NF-kappaB signaling by longevity factors FoxOs and SIRT1. Cell Mol Life Sci 2008,65(7-8),1049-1058","journal-title":"Cell Mol Life Sci"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"Morgan M.J.","year":"2011","unstructured":"Morgan M.J.; Liu Z.G.; Crosstalk of reactive oxygen species and NF-\u03baB signaling. Cell Res 2011,21(1),103-115","journal-title":"Cell Res"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"215S","DOI":"10.1093\/ajcn\/81.1.215S","volume":"81","author":"Scalbert A.","year":"2005","unstructured":"Scalbert A.; Johnson I.T.; Saltmarsh M.; Polyphenols: Antioxidants and beyond. Am J Clin Nutr 2005,81(1)(Suppl.),215S-217S","journal-title":"Am J Clin Nutr"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fimmu.2013.00226","volume":"4","author":"Schilderink R.","year":"2013","unstructured":"Schilderink R.; Verseijden C.; de Jonge W.J.; Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front Immunol 2013,4,226","journal-title":"Front Immunol"},{"key":"ref=174","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/cdd.2011.29","volume":"18","year":"2011","unstructured":"Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia. Cell Death Differ Neubert M, Ridder A, Bargiotas P, Akira S, Schwaninger M2011,18(9),1521-1530","journal-title":"Cell Death Differ"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/biology8020043","volume":"8","author":"Surguchov A.","year":"2019","unstructured":"Surguchov A.; Emamzadeh F.N.; Surguchev A.A.; Amyloidosis and Longevity: A Lesson from Plants. Biology (Basel) 2019,8(2),43","journal-title":"Biology (Basel)"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.abb.2014.05.017","volume":"559","author":"Sandoval-Acu\u00f1a C.","year":"2014","unstructured":"Sandoval-Acu\u00f1a C.; Ferreira J.; Speisky H.; Polyphenols and mitochondria: An update on their increasingly emerging ROS-scavenging independent actions. Arch Biochem Biophys 2014,559,75-90","journal-title":"Arch Biochem Biophys"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1021\/jf8008553","volume":"56","author":"Kim M.Y.","year":"2008","unstructured":"Kim M.Y.; Seguin P.; Ahn J.K.; Kim J.J.; Chun S.C.; Kim E.H.; Seo S.H.; Kang E.Y.; Kim S.L.; Park Y.J.; Ro H.M.; Chung I.M.; Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. J Agric Food Chem 2008,56(16),7265-7270","journal-title":"J Agric Food Chem"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1021\/jf300739m","volume":"60","author":"Heleno S.A.","year":"2012","unstructured":"Heleno S.A.; Barros L.; Martins A.; Queiroz M.J.; Santos-Buelga C.; Ferreira I.C.; Phenolic, polysaccharidic, and lipidic fractions of mushrooms from northeastern Portugal: Chemical compounds with antioxidant properties. J Agric Food Chem 2012,60(18),4634-4640","journal-title":"J Agric Food Chem"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1128\/MCB.23.22.8137-8151.2003","volume":"23","author":"Zhang D.D.","year":"2003","unstructured":"Zhang D.D.; Hannink M.; Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 2003,23(22),8137-8151","journal-title":"Mol Cell Biol"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.biotechadv.2017.12.015","volume":"36","author":"Matzinger M.","year":"2018","unstructured":"Matzinger M.; Fischhuber K.; Heiss E.H.; Activation of Nrf2 signaling by natural products-can it alleviate diabetes? Biotechnol Adv 2018,36(6),1738-1767","journal-title":"Biotechnol Adv"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/antiox6040073","volume":"6","author":"Mart\u00ednez-Hu\u00e9lamo M.","year":"2017","unstructured":"Mart\u00ednez-Hu\u00e9lamo M.; Rodr\u00edguez-Morat\u00f3 J.; Boronat A.; de la Torre R.; Modulation of Nrf2 by olive oil and wine polyphenols and neuroprotection. Antioxidants 2017,6(4),73","journal-title":"Antioxidants"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12035-011-8181-5","volume":"44","author":"Scapagnini G.","year":"2011","unstructured":"Scapagnini G.; Vasto S.; Abraham N.G.; Caruso C.; Zella D.; Fabio G.; Modulation of Nrf2\/ARE pathway by food polyphenols: A nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 2011,44(2),192-201","journal-title":"Mol Neurobiol"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/nu10111618","volume":"10","author":"Yahfoufi N.","year":"2018","unstructured":"Yahfoufi N.; Alsadi N.; Jambi M.; Matar C.; The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients 2018,10(11),1618","journal-title":"Nutrients"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1089\/ars.2013.5703","volume":"20","author":"Nayernia Z.","year":"2014","unstructured":"Nayernia Z.; Jaquet V.; Krause K.H.; New insights on NOX enzymes in the central nervous system. Antioxid Redox Signal 2014,20(17),2815-2837","journal-title":"Antioxid Redox Signal"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/428010","volume":"2012","author":"Gandhi S","year":"2012","unstructured":"Gandhi S; Abramov AY; Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev 2012,2012,1-11","journal-title":"Oxid Med Cell Longev"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1046\/j.1471-4159.1999.0732310.x","volume":"73","author":"Cohen G.","year":"1999","unstructured":"Cohen G.; Kesler N.; Monoamine oxidase and mitochondrial respiration. J Neurochem 1999,73(6),2310-2315","journal-title":"J Neurochem"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10787-007-1614-0","volume":"16","author":"Rajeswari A.","year":"2008","unstructured":"Rajeswari A.; Sabesan M.; Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson\u2019s disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 2008,16(2),96-99","journal-title":"Inflammopharmacology"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.3390\/ijms19092757","volume":"19","author":"Wood Dos Santos T.","year":"2018","unstructured":"Wood Dos Santos T.; Cristina Pereira Q.; Teixeira L.; Gambero A.; A Villena J.; Lima Ribeiro M.; Effects of polyphenols on thermogenesis and mitochondrial biogenesis. Int J Mol Sci 2018,19(9),2757","journal-title":"Int J Mol Sci"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10571-015-0222-6","volume":"36","author":"Dong W.","year":"2016","unstructured":"Dong W.; Wang F.; Guo W.; Zheng X.; Chen Y.; Zhang W.; Shi H.; A\u03b225-35 suppresses mitochondrial biogenesis in primary hippocampal neurons. Cell Mol Neurobiol 2016,36(1),83-91","journal-title":"Cell Mol Neurobiol"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cmet.2013.02.004","volume":"17","author":"Xu W.","year":"2013","unstructured":"Xu W.; Barrientos T.; Andrews N.C.; Iron and copper in mitochondrial diseases. Cell Metab 2013,17(3),319-328","journal-title":"Cell Metab"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.fct.2018.02.022","volume":"114","author":"Xiao L.","year":"2018","unstructured":"Xiao L.; Luo G.; Tang Y.; Yao P.; Quercetin and iron metabolism: What we know and what we need to know. Food Chem Toxicol 2018,114,190-203","journal-title":"Food Chem Toxicol"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jinorgbio.2008.11.003","volume":"103","author":"Perez C.A.","year":"2009","unstructured":"Perez C.A.; Wei Y.; Guo M.; Iron-binding and anti-Fenton properties of baicalein and baicalin. J Inorg Biochem 2009,103(3),326-332","journal-title":"J Inorg Biochem"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.saa.2012.12.041","volume":"105","author":"Refat M.S.","year":"2013","unstructured":"Refat M.S.; Synthesis and characterization of ligational behavior of curcumin drug towards some transition metal ions: Chelation effect on their thermal stability and biological activity. Spectrochim Acta A Mol Biomol Spectrosc 2013,105,326-337","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.arr.2012.03.008","volume":"12","author":"Pallauf K.","year":"2013","unstructured":"Pallauf K.; Rimbach G.; Autophagy, polyphenols and healthy ageing. Ageing Res Rev 2013,12(1),237-252","journal-title":"Ageing Res Rev"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2174\/187152012802649978","volume":"12","author":"Shen M.","year":"2012","unstructured":"Shen M.; Chan T.H.; Dou Q.P.; Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization. Anticancer Agents Med Chem 2012,12(8),891-901","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jff.2015.03.043","volume":"15","author":"Vald\u00e9s A.","year":"2015","unstructured":"Vald\u00e9s A.; Sullini G.; Ib\u00e1\u00f1ez E.; Cifuentes A.; Garc\u00eda-Ca\u00f1as V.; Rosemary polyphenols induce unfolded protein response and changes in cholesterol metabolism in colon cancer cells. J Funct Foods 2015,15,429-439","journal-title":"J Funct Foods"},{"key":"ref=197","author":"Huang Y","year":"2018","unstructured":"Huang Y; Chen Y; Shaw AM; Goldfine H; Tian J; Cai J; Enhancing TFEB-mediated cellular degradation pathways by the mTORC1 inhibitor quercetin. Oxid Med Cell Longev 2018","journal-title":"Oxid Med Cell Longev"},{"key":"ref=198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8067592","author":"Miceli C","year":"2018","unstructured":"Miceli C; Santin Y; Manzella N; Oleuropein aglycone protects against mao-a-induced autophagy impairment and cardiomyocyte death through activation of TFEB. Oxid Med Cell Longev 2018,1-13","journal-title":"Oxid Med Cell Longev"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"75659","DOI":"10.18632\/oncotarget.12318","volume":"7","author":"Zhang J.","year":"2016","unstructured":"Zhang J.; Wang J.; Xu J.; Lu Y.; Jiang J.; Wang L.; Shen H.M.; Xia D.; Curcumin targets the TFEB-lysosome pathway for induction of autophagy. Oncotarget 2016,7(46),75659-75671","journal-title":"Oncotarget"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"e0152064","DOI":"10.1371\/journal.pone.0152064","volume":"11","author":"Cai S.","year":"2016","unstructured":"Cai S.; Yang H.; Zeng K.; Zhang J.; Zhong N.; Wang Y.; Ye J.; Tu P.; Liu Z.; EGCG inhibited lipofuscin formation based on intercepting amyloidogenic \u03b2-sheet-rich structure conversion. PLoS One 2016,11(3),e0152064","journal-title":"PLoS One"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10522-013-9466-z","volume":"15","author":"Rastogi M.","year":"2014","unstructured":"Rastogi M.; Ojha R.P.; Sagar C.; Agrawal A.; Dubey G.P.; Protective effect of curcuminoids on age-related mitochondrial impairment in female Wistar rat brain. Biogerontology 2014,15(1),21-31","journal-title":"Biogerontology"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.abb.2010.05.003","volume":"501","author":"Chung S.","year":"2010","unstructured":"Chung S.; Yao H.; Caito S.; Hwang J.W.; Arunachalam G.; Rahman I.; Regulation of SIRT1 in cellular functions: Role of polyphenols. Arch Biochem Biophys 2010,501(1),79-90","journal-title":"Arch Biochem Biophys"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.phrs.2009.12.006","volume":"62","author":"Yu J.","year":"2010","unstructured":"Yu J.; Auwerx J.; Protein deacetylation by SIRT1: An emerging key post-translational modification in metabolic regulation. Pharmacol Res 2010,62(1),35-41","journal-title":"Pharmacol Res"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/BST20170121","volume":"46","author":"Maiese K.","year":"2018","unstructured":"Maiese K.; The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): Oversight for neurodegenerative disorders. Biochem Soc Trans 2018,46(2),351-360","journal-title":"Biochem Soc Trans"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13238-016-0269-2","volume":"7","author":"Bao J.","year":"2016","unstructured":"Bao J.; Zheng L.; Zhang Q.; Li X.; Zhang X.; Li Z.; Bai X.; Zhang Z.; Huo W.; Zhao X.; Shang S.; Wang Q.; Zhang C.; Ji J.; Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia. Protein Cell 2016,7(6),417-433","journal-title":"Protein Cell"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","volume":"20","author":"Palmieri M.","year":"2011","unstructured":"Palmieri M.; Impey S.; Kang H.; di Ronza A.; Pelz C.; Sardiello M.; Ballabio A.; Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet 2011,20(19),3852-3866","journal-title":"Hum Mol Genet"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/0929867321666140706130807","volume":"22","author":"Xiao J.B.","year":"2015","unstructured":"Xiao J.B.; H\u00f6gger P.; Dietary polyphenols and type 2 diabetes: Current insights and future perspectives. Curr Med Chem 2015,22(1),23-38","journal-title":"Curr Med Chem"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/antiox8050137","volume":"8","author":"Rodr\u00edguez-Garc\u00eda C.","year":"2019","unstructured":"Rodr\u00edguez-Garc\u00eda C.; S\u00e1nchez-Quesada C.; J Gaforio J.; Dietary flavonoids as cancer chemopreventive agents: An updated review of human studies. Antioxidants 2019,8(5),137","journal-title":"Antioxidants"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/ijms19030765","volume":"19","author":"Nirumand M.C.","year":"2018","unstructured":"Nirumand M.C.; Hajialyani M.; Rahimi R.; Farzaei M.H.; Zingue S.; Nabavi S.M.; Bishayee A.; Dietary plants for the prevention and management of kidney stones: Preclinical and clinical evidence and molecular mechanisms. Int J Mol Sci 2018,19(3),765","journal-title":"Int J Mol Sci"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.2337\/db05-1188","volume":"55","author":"Zang M.","year":"2006","unstructured":"Zang M.; Xu S.; Maitland-Toolan K.A.; Zuccollo A.; Hou X.; Jiang B.; Wierzbicki M.; Verbeuren T.J.; Cohen R.A.; Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006,55(8),2180-2191","journal-title":"Diabetes"},{"key":"ref=211","first-page":"183","volume":"201","author":"Geelen MH","year":"1986","unstructured":"Geelen MH; Gibson D; Hydroxymethylglutaryl-CoA reductase-the rate-limiting enzyme of cholesterol biosynthesis: A report of a meeting held at Nijenrode Castle, Breukelen, The Netherlands 1986,201(2),183-6","journal-title":"Hydroxymethylglutaryl-CoA reductase-the rate-limiting enzyme of cholesterol biosynthesis: A report of a meeting held at Nijenrode Castle, Breukelen, The Netherlands"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.biochi.2016.12.012","volume":"136","author":"Barquissau V.","year":"2017","unstructured":"Barquissau V.; Ghandour R.A.; Ailhaud G.; Klingenspor M.; Langin D.; Amri E.Z.; Pisani D.F.; Control of adipogenesis by oxylipins, GPCRs and PPARs. Biochimie 2017,136,3-11","journal-title":"Biochimie"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.bbrc.2016.06.078","volume":"477","author":"Wang S.","year":"2016","unstructured":"Wang S.; Zhang Q.; Zhang Y.; Shen C.; Wang Z.; Wu Q.; Zhang Y.; Li S.; Qiao Y.; Agrimol B suppresses adipogenesis through modulation of SIRT1-PPAR gamma signal pathway. Biochem Biophys Res Commun 2016,477(3),454-460","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"Singh R.","year":"2009","unstructured":"Singh R.; Kaushik S.; Wang Y.; Xiang Y.; Novak I.; Komatsu M.; Tanaka K.; Cuervo A.M.; Czaja M.J.; Autophagy regulates lipid metabolism. Nature 2009,458(7242),1131-1135","journal-title":"Nature"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1172\/JCI0216390","volume":"110","author":"Simons K.","year":"2002","unstructured":"Simons K.; Ehehalt R.; Cholesterol, lipid rafts, and disease. J Clin Invest 2002,110(5),597-603","journal-title":"J Clin Invest"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.3390\/ijms20143531","volume":"20","author":"Dhakal S.","year":"2019","unstructured":"Dhakal S.; Subhan M.; Fraser J.M.; Gardiner K.; Macreadie I.; Simvastatin efficiently reduces levels of alzheimer\u2019s amyloid beta in yeast. Int J Mol Sci 2019,20(14),3531","journal-title":"Int J Mol Sci"},{"key":"ref=217","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bcp.2018.07.050","volume":"156","author":"Tresserra-Rimbau A","year":"2018","unstructured":"Tresserra-Rimbau A; Lamuela-Raventos RM; Moreno JJJBP; Polyphenols, food and pharma. Biochem Pharmacol 2018,156,186-95","journal-title":"Biochem Pharmacol"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3390\/ijms20081883","volume":"20","author":"Renaud J.","year":"2019","unstructured":"Renaud J.; Martinoli M.G.; Considerations for the use of polyphenols as therapies in neurodegenerative diseases. Int J Mol Sci 2019,20(8),1883","journal-title":"Int J Mol Sci"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.toxlet.2015.05.009","volume":"236","author":"Margin\u0103 D.","year":"2015","unstructured":"Margin\u0103 D.; Ilie M.; Gr\u0103dinaru D.; Androutsopoulos V.P.; Kouretas D.; Tsatsakis A.M.; Natural products-friends or foes? Toxicol Lett 2015,236(3),154-167","journal-title":"Toxicol Lett"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-2797(01)00285-X","volume":"139","author":"Hodek P.","year":"2002","unstructured":"Hodek P.; Trefil P.; Stiborov\u00e1 M.; Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 2002,139(1),1-21","journal-title":"Chem Biol Interact"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1365-2125.1998.00764.x","volume":"46","author":"Bailey D.G.","year":"1998","unstructured":"Bailey D.G.; Malcolm J.; Arnold O.; Spence J.D.; Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998,46(2),101-110","journal-title":"Br J Clin Pharmacol"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0300-483X(99)00215-2","volume":"144","author":"Doostdar H.","year":"2000","unstructured":"Doostdar H.; Burke M.D.; Mayer R.T.; Bioflavonoids: Selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 2000,144(1-3),31-38","journal-title":"Toxicology"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jpsychires.2012.03.003","volume":"46","author":"Herrschaft H.","year":"2012","unstructured":"Herrschaft H.; Nacu A.; Likhachev S.; Sholomov I.; Hoerr R.; Schlaefke S.; Ginkgo biloba extract EGb 761\u00ae in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J Psychiatr Res 2012,46(6),716-723","journal-title":"J Psychiatr Res"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/alzrt146","volume":"4","author":"Ringman J.M.","year":"2012","unstructured":"Ringman J.M.; Frautschy S.A.; Teng E.; Begum A.N.; Bardens J.; Beigi M.; Gylys K.H.; Badmaev V.; Heath D.D.; Apostolova L.G.; Porter V.; Vanek Z.; Marshall G.A.; Hellemann G.; Sugar C.; Masterman D.L.; Montine T.J.; Cummings J.L.; Cole G.M.; Oral curcumin for Alzheimer\u2019s disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 2012,4(5),43","journal-title":"Alzheimers Res Ther"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/s-0031-1291217","volume":"45","author":"Ihl R.","year":"2012","unstructured":"Ihl R.; Tribanek M.; Bachinskaya N.; Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761\u00ae in Alzheimer\u2019s disease and vascular dementia: Results from a randomised controlled trial. Pharmacopsychiatry GOTADAY Study Group2012,45(2),41-46","journal-title":"Pharmacopsychiatry"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1158\/1055-9965.EPI-07-0022","volume":"16","author":"Boocock D.J.","year":"2007","unstructured":"Boocock D.J.; Faust G.E.; Patel K.R.; Schinas A.M.; Brown V.A.; Ducharme M.P.; Booth T.D.; Crowell J.A.; Perloff M.; Gescher A.J.; Steward W.P.; Brenner D.E.; Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007,16(6),1246-1252","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"564","DOI":"10.5414\/CPP46564","volume":"46","author":"Vaz-da-Silva M.","year":"2008","unstructured":"Vaz-da-Silva M.; Loureiro A.I.; Falcao A.; Nunes T.; Rocha J.F.; Fernandes-Lopes C.; Soares E.; Wright L.; Almeida L.; Soares-da-Silva P.; Effect of food on the pharmacokinetic profile of trans-resveratrol. Int J Clin Pharmacol Ther 2008,46(11),564-570","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3892\/etm.2015.2895","volume":"11","author":"Sergides C.","year":"2016","unstructured":"Sergides C.; Chiril\u0103 M.; Silvestro L.; Pitta D.; Pittas A.; Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers. Exp Ther Med 2016,11(1),164-170","journal-title":"Exp Ther Med"},{"key":"ref=229","first-page":"3312","volume":"9","author":"Chow H.H.","year":"2003","unstructured":"Chow H.H.; Cai Y.; Hakim I.A.; Crowell J.A.; Shahi F.; Brooks C.A.; Dorr R.T.; Hara Y.; Alberts D.S.; Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003,9(9),3312-3319","journal-title":"Clin Cancer Res"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2174\/1570159X14666161026151545","volume":"15","author":"Figueira I.","year":"2017","unstructured":"Figueira I.; Menezes R.; Macedo D.; Costa I.; Dos Santos C.N.; Polyphenols beyond barriers: A glimpse into the Brain. Curr Neuropharmacol 2017,15(4),562-594","journal-title":"Curr Neuropharmacol"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","volume":"85","author":"Turner R.S.","year":"2015","unstructured":"Turner R.S.; Thomas R.G.; Craft S.; van Dyck C.H.; Mintzer J.; Reynolds B.A.; Brewer J.B.; Rissman R.A.; Raman R.; Aisen P.S.; A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology Alzheimer\u2019s Disease Cooperative Study2015,85(16),1383-1391","journal-title":"Neurology"},{"key":"ref=232","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/gps.2662","volume":"26","author":"Ihl R.","year":"2011","unstructured":"Ihl R.; Bachinskaya N.; Korczyn A.D.; Vakhapova V.; Tribanek M.; Hoerr R.; Napryeyenko O.; Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: A randomized controlled trial. Int J Geriatr Psychiatry GOTADAY Study Group2011,26(11),1186-1194","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/hup.2534","volume":"31","author":"Beck S.M.","year":"2016","unstructured":"Beck S.M.; Ruge H.; Schindler C.; Burkart M.; Miller R.; Kirschbaum C.; Goschke T.; Effects of Ginkgo biloba extract EGb 761\u00ae on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment - a randomized double-blind placebo-controlled trial. Hum Psychopharmacol 2016,31(3),227-242","journal-title":"Hum Psychopharmacol"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00702-016-1507-8","volume":"123","author":"Levin J.","year":"2016","unstructured":"Levin J.; Maa\u00df S.; Schuberth M.; Respondek G.; Paul F.; Mansmann U.; Oertel W.H.; Lorenzl S.; Krismer F.; Seppi K.; Poewe W.; Wenning G.; Giese A.; B\u00f6tzel K.; H\u00f6glinger G.; The PROMESA-protocol: Progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach. J Neural Transm (Vienna) PROMESA study group2016,123(4),439-445","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuint.2015.07.003","volume":"89","author":"Pandareesh M.D.","year":"2015","unstructured":"Pandareesh M.D.; Mythri R.B.; Srinivas Bharath M.M.; Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases. Neurochem Int 2015,89,198-208","journal-title":"Neurochem Int"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1021\/acs.molpharmaceut.7b00545","volume":"14","author":"Hu M.","year":"2017","unstructured":"Hu M.; Wu B.; Liu Z.; Bioavailability of Polyphenols and Flavonoids in the Era of Precision Medicine. Mol Pharm 2017,14(9),2861-2863","journal-title":"Mol Pharm"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","volume":"79","author":"Manach C.","year":"2004","unstructured":"Manach C.; Scalbert A.; Morand C.; R\u00e9m\u00e9sy C.; Jim\u00e9nez L.; Polyphenols: Food sources and bioavailability. Am J Clin Nutr 2004,79(5),727-747","journal-title":"Am J Clin Nutr"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1753-4887.1998.tb01670.x","volume":"56","author":"Bravo L.","year":"1998","unstructured":"Bravo L.; Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998,56(11),317-333","journal-title":"Nutr Rev"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0753-3322(02)00205-6","volume":"56","author":"Scalbert A.","year":"2002","unstructured":"Scalbert A.; Morand C.; Manach C.; R\u00e9m\u00e9sy C.; Absorption and metabolism of polyphenols in the gut and impact on health. Biomed Pharmacother 2002,56(6),276-282","journal-title":"Biomed Pharmacother"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2174\/138920006778520570","volume":"7","author":"Cermak R.","year":"2006","unstructured":"Cermak R.; Wolffram S.; The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms. Curr Drug Metab 2006,7(7),729-744","journal-title":"Curr Drug Metab"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","volume":"16","author":"Ballabh P.","year":"2004","unstructured":"Ballabh P.; Braun A.; Nedergaard M.; The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol Dis 2004,16(1),1-13","journal-title":"Neurobiol Dis"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"11456","DOI":"10.1038\/s41598-017-11512-6","volume":"7","author":"Figueira I.","year":"2017","unstructured":"Figueira I.; Garcia G.; Pimp\u00e3o R.C.; Terrasso A.P.; Costa I.; Almeida A.F.; Tavares L.; Pais T.F.; Pinto P.; Ventura M.R.; Filipe A.; McDougall G.J.; Stewart D.; Kim K.S.; Palmela I.; Brites D.; Brito M.A.; Brito C.; Santos C.N.; Polyphenols journey through blood-brain barrier towards neuronal protection. Sci Rep 2017,7(1),11456","journal-title":"Sci Rep"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bcp.2018.05.016","volume":"154","author":"Squillaro T.","year":"2018","unstructured":"Squillaro T.; Cimini A.; Peluso G.; Giordano A.; Melone M.A.B.; Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for neurodegenerative diseases and brain tumors. Biochem Pharmacol 2018,154,303-317","journal-title":"Biochem Pharmacol"},{"key":"ref=244","doi-asserted-by":"publisher","DOI":"10.3390\/biom9020056","volume":"9","author":"Del Prado-Audelo M.L.","year":"2019","unstructured":"Del Prado-Audelo M.L.; Caballero-Flor\u00e1n I.H.; Meza-Toledo J.A.; Mendoza-Mu\u00f1oz N.; Gonz\u00e1lez-Torres M.; Flor\u00e1n B.; Cort\u00e9s H.; Leyva-G\u00f3mez G.; Formulations of curcumin nanoparticles for brain diseases. Biomolecules 2019,9(2)","journal-title":"Biomolecules"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.2147\/IJN.S208332","volume":"14","author":"Yavarpour-Bali H.","year":"2019","unstructured":"Yavarpour-Bali H.; Ghasemi-Kasman M.; Pirzadeh M.; Curcumin-loaded nanoparticles: A novel therapeutic strategy in treatment of central nervous system disorders. Int J Nanomedicine 2019,14,4449-4460","journal-title":"Int J Nanomedicine"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tifs.2014.05.003","volume":"38","author":"Davidov-Pardo G.","year":"2014","unstructured":"Davidov-Pardo G.; McClements D.J.; Resveratrol encapsulation: Designing delivery systems to overcome solubility, stability and bioavailability issues. Trends Food Sci Technol 2014,38(2),88-103","journal-title":"Trends Food Sci Technol"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/acel.12345","volume":"14","author":"Mei Y","year":"2015","unstructured":"Mei Y; Jiang C; Wan Y; Aging-associated formaldehyde-induced norepinephrine deficiency contributes to age-related memory decline. Aging Cell 2015,14(4),659-668","journal-title":"Aging Cell"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/sj.cdd.4401088","volume":"9","author":"van Loo G","year":"2002","unstructured":"van Loo G; Saelens X; Van Gurp M; The role of mitochondrial factors in apoptosis: A Russian roulette with more than one bullet. Cell Death Differ 2002,9(10),1031-42","journal-title":"Cell Death Differ"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00401-007-0250-5","volume":"114","author":"Beach TG","year":"2007","unstructured":"Beach TG; Sue LI; Walker DG; Marked microglial reaction in normal aging human substantia nigra: Correlation with extraneuronal neuromelanin pigment deposits. Acta Neuropathol 2007,114(4),419-24","journal-title":"Acta Neuropathol"},{"key":"ref=250","first-page":"160","volume":"14","author":"Braakhuis AJ","year":"2014","unstructured":"Braakhuis AJ; Hopkins WG; Effects of dietary antioxidants on training and performance in female runners. 2014,14(2),160-8"},{"key":"ref=251","first-page":"21","volume":"4","author":"Askari G","year":"2013","unstructured":"Askari G; Ghiasvand R; Paknahad Z; Karimian J; Rabiee K; Sharifirad G; The effects of quercetin supplementation on body composition, exercise performance and muscle damage indices in athletes. Int J Prev Med 2013,4(1),21-26","journal-title":"Int J Prev Med"},{"key":"ref=252","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1123\/ijsnem.20.1.56","volume":"20","author":"Davis JM","year":"2010","unstructured":"Davis JM; Carlstedt CJ; Chen S; Carmichael MD; Murphy EA; The dietary flavonoid quercetin increases VO2max and endurance capacity. Int J Sport Nutr Exerc Metab 2010,20(1),56-62","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1152\/japplphysiol.00234.2009","volume":"107","author":"Cureton KJ","year":"2009","unstructured":"Cureton KJ; Tomporowski PD; Singhal A; Dietary quercetin supplementation is not ergogenic in untrained men. J Appl Physiol 2009,107(4),1095-1104","journal-title":"J Appl Physiol"},{"key":"ref=254","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3164\/jcbn.11-46","volume":"50","author":"Kang SW","year":"2012","unstructured":"Kang SW; Hahn S; Kim J-K; Yang S-M; Park B-J; Oligomerized Lychee Fruit Extract (OLFE) and a mixture of vitamin C and vitamin E for endurance capacity in a double blind randomized controlled trial. J Clin Biochem Nutr 2012,50(2),106-113","journal-title":"J Clin Biochem Nutr"},{"key":"ref=255","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1123\/ijsnem.16.4.405","volume":"16","author":"MacRae HS","year":"2006","unstructured":"MacRae HS; Mefferd KM; Dietary antioxidant supplementation combined with quercetin improves cycling time trial performance. Int J Sport Nutr Exerc Meta 2006,16(4),405-19","journal-title":"Int J Sport Nutr Exerc Meta"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1139\/apnm-2014-0070","volume":"39","author":"Scribbans TD","year":"2014","unstructured":"Scribbans TD; Ma JK; Edgett BA; Vorobej KA; Mitchell AS; Zelt JG; Resveratrol supplementation does not augment performance adaptations or fibre-type\u2013specific responses to high-intensity interval training in humans. Appl Physiol Nutr Metab 2014,39(11),1305-1313","journal-title":"Appl Physiol Nutr Metab"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1249\/MSS.0b013e3181b18fa3","volume":"42","author":"Nieman DC","year":"2010","unstructured":"Nieman DC; Williams AS; Shanely RA; Jin F; McAnulty SR; Triplett NT; Quercetin\u2019s influence on exercise performance and muscle mitochondrial biogenesis. Med Sci Sports Exerc 2010,42(2),338-45","journal-title":"Med Sci Sports Exerc"},{"key":"ref=258","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/OAJSM.S83159","volume":"6","author":"Scholten SD","year":"2015","unstructured":"Scholten SD; Sergeev IN; Song Q; Effects of vitamin D and quercetin, alone and in combination, on cardiorespiratory fitness and muscle function in physically active male adults. Open Access J Sports Med 2015,6,229-239","journal-title":"Open Access J Sports Med"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/191526","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191526\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/191526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T13:48:21Z","timestamp":1724507301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191526\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":258,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527320666210218084444","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-06-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}